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1 Abbreviations 
 
A adenine 
Ab antibody 
B bulge 
BCA bicinchonic acid 
BCC basal cell carcinoma 
BL basal layer 
BM basement membrane 
BMP Bone Morphogenetic Protein 
BP base pairs 
BrdU Bromodeoxyuridine (5-bromo-2'-deoxyuridine) 
BSA bovine serum albumin 
°C degree Celsius 
cDNA complementary DNA 
CL cornified layer 
c-Myc cellular myelo cytomatosis oncogene 
CO2 carbon dioxide 
Cre site specific recombinase from phage P1 (causes recombination) 
CS Cockayne syndromeb 
DAPI 4`6-Diamidino-2-phenylindol 
DE dermis      
Dhh Desert hedgehog 
DMBA 7,12-dimethylbenz-[a]-anthracene 
DMEM Dulbecco`s modified Eagle’s Medium 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
DP dermal papilla 
DSB double stand breaks 
E  embryonic day 
ECL enhanced chemiluminescence 
ECM extracellular matrix 
              Abbreviation 
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EDTA ethylene diamine tetra acetic acid 
EGF epidermal growth factor 
EtOH ethanol 
FACS fluorescence activated cell sorting 
FCS fetal calf serum 
Ihh Indian hedgehog 
Ihh EKO epidermal specific Ihh knockout 
g  gram 
GFP green fluorescent protein 
GL  Granular layer 
Gli glioma-associated oncogene homolog 
GSK3 Glycogen synthase kinase 3 
GTP  Guanosintriphosphat 
H hours 
HCL hydrochloric acid 
H&E hematoxylin-eosin 
HF hair follicle 
HG hair germ 
Hh Hedgehog 
HR homologous recombination 
HRP horse radish peroxidase 
Hz hertz 
IF immunofluorescent 
IFE interfollicular epidermis 
IRS inner root sheath 
IU international unit 
IZ isthmus zone 
JZ junctional zone 
K keratin 
K6a keratin 6a 
K10 keratin 10 
K14 keratin 14 
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kDa kilo Dalton 
Ki67 Kiel 67 (university of Kiel) 
KO knockout 
Lef1 Lymphoid enhancer-binding factor 1 
LRC label retaining cells 
M Mol 
mAB monoclonal antibody 
Mdm2 Murine double minute 2 
μg micro geram 
mg milligram 
min  minute 
μl micro liter 
ml milliliter 
μm micro molar 
mM millimolar 
mRNA messenger RNA 
MZ mature sebocytes 
n nano 
NER nucleotide excision repair 
Ng nanogram 
NGS normal goat serum 
nm nanometer 
NP-40 nonidet P-40 
ORS outer root sheat 
P postnatal day 
PAGE polyacrylamide gel electrophoresis 
PAP papilloma 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PDK1 phosphoinositide-dependent protein kinase 1 
PFA paraformaldehyde 
PI propidium iodide 
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PI3K phosphatidylinositol 3 kinase 
PKA protein kinase A 
Ptch patched 
RNA ribonucleic acid 
RNAi RNA interference 
Rpm rounds per minute 
SC stem cell 
SDS sodium dodecyl sulphate 
Sec seconds 
Ser Serine 
SG sebaceous gland 
Shh Sonic hedgehog 
SL Spinous layer 
s-Me s-mercaptoethanol 
Smo smoothened 
Sufu Suppressor of Fused 
TAE Tris-acetic acid-EDTA-buffer 
TBS tris buffered saline 
TE Tris-EDTA buffered 
TF Transcription factor  
Tg Transgenic 
TPA 12-O-Tetradecanoylphorbol-13-acetat 
U unit 
UV ultraviolet 
V volt 
vs. versus 
v/v  volume/volume 
WB western blot  
WM whole mounts 
Wt wild-type 
w/v weight per volume 
XP Xeroderma pigmentos
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2 Abstract 
 
The Hedgehog (Hh) signalling pathway plays an essential role during mammalian skin 
development and epidermal regeneration. Out of the three mammalian Hh homologs, Sonic 
hedgehog (Shh) is the best characterised Hh ligand in the skin. Shh is expressed during hair 
morphogenesis and is required for hair follicle formation and cyclic hair regeneration. 
Mutations in Shh and other components of the Hh pathway result in skin abnormalities and 
tumour formation, e.g. Basal Cell Carcinoma (BCC), the most common cancer in humans. 
Indian hedgehog (Ihh) is expressed in the sebaceous gland (SG), a hair follicle associated 
epidermal appendage, which secretes sebum to lubricate and protect the skin. However, an in 
vivo function for Ihh has not been identified in the skin. In vitro studies indicated that 
components of the Hh pathway are up-regulated and activity of the pathway is increased 
upon differentiation of human sebocytes. Furthermore, it was shown that activation of Hh 
signalling in basal keratinocytes promotes ectopic SG and sebaceous duct formation. Analysis 
of sebaceous tumours in mouse models and in humans demonstrated expression of Ihh in 
mature tumour cells. These observations led to the hypothesis that Ihh could be an important 
factor regulating differentiation and tumour formation in the skin. To address these issues, an 
epidermis-specific Ihh knockout (Ihh EKO) was generated. The absence of epidermal Ihh 
significantly inhibits proliferation in early skin development however; morphogenesis of SGs, 
hair follicles and the interfollicular epidermis was not altered. Importantly, a function of Ihh 
for tumourigenesis was identified. In particular, Ihh increases the size of tumours and induces 
SG and sebaceous duct fate differentiation and this was accompanied by a reduced number of 
follicular progenitors. In addition, Ihh signalling promoted proliferation and regulated p53 in 
squamous epidermal tumours. The results indicate that regulation of p53 constitutes a 
general function of Ihh in keratinocytes and that Ihh plays an important role in patho-
physiological conditions of the skin.  
              Zusammenfassung 
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2.1  Zusammenfassung 
 
Der Hedgehog (Hh) Signalweg spielt für die Entwicklung und Regeneration der Haut der 
Säugetiere eine wichtige Rolle. Unter den drei Hh Liganden, Sonic Hedgehog (Shh), Indian 
Hedgehog (Ihh) und Dessert Hedgehog (Dhh), ist die Rolle von Shh am besten untersucht. 
Shh wird im wachsenden Haarfollikel exprimiert, wo es während der Haarfollikelbildung und 
der zyklischen Regeneration des Haares inbesondere die Proliferation der Keratinozyten 
kontrolliert. Die Aktivierung des Signalweges, z.B. durch Mutationen in dem Rezeptor 
Patched, führt zu Störungen der Hautentwicklung und zu Tumoren, unter denen das 
Basalzellkarzinom (BCC) die am häufigsten auftretende menschliche Krebserkrankung 
darstellt. Der Ligand Ihh wird in der Talgdrüse exprimiert, die häufig mit dem Haarfollikel 
assoziiert vorliegt. Bisher ist über die Funktion von Ihh in der Haut wenig bekannt. In vitro 
Studien zeigten, dass während der Differenzierung humaner Sebozyten die Expression von 
Komponten und die Aktivität des Hh Signalwegs erhöht sind. Eine Aktivierung des Hh 
Signalwegs in der Basalschicht der Epidermis führt zur Bildung ektopischer Talgdrüsen und 
Talgdrüsengänge. Die Analyse von Talgdrüsentumoren beim Menschen und der Maus zeigt, 
dass Ptch1 und Gli1 erhöht exprimiert sind, was darauf hinweist, dass  der Hh Siganlweg in 
diesen Tumoren aktiviert ist. Ihh wird in Talgdrüsentumoren ebenfalls stark expimiert, 
wohingegen Shh und Dhh nicht detektierbar sind. Diese Beobachtungen führten zur 
Hypothese, dass Ihh für die Proliferation, Differenzierung und Tumorbildung in der Haut von 
großer Bedeutung ist. Um die Funktion von Ihh in der Haut zu untersuchen, wurden Mäuse 
generiert, in denen Ihh spezifisch im Epithel der Haut ausgeschaltet wurde (Ihh EKO). Der 
Verlust von Ihh in der Haut führt zwar zu einer verringerten Proliferation in der Epidermis 
von jungen Tieren, jedoch wurden keine offensichtlichen morphologischen Defekte 
beobachtet. Im Gegensatz dazu führt der Verlust von Ihh zu reduzierter Proliferation und zu 
veränderter Differenzierung in Talgdrüsentumoren. In Plattenephitelkarzinomen waren in 
Ihh EKO Mäusen ebenfalls die Proliferation und Differenzierung der Kerationzyten deutlich 
verändert. Des Weiteren führt  der Verlust von Ihh in der normalen Haut als auch in 
Tumoren zu einer nuklearen Akkumulation von p53.  Die Daten zeigen deutlich, daß Ihh 
neben der Regulation der Differenzierung von Sebozyten eine wichtige Funktion in der 
Kontrolle von Proliferation und p53 Aktivität der Haut hat.  
              Introduction 
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3 Introduction 
 
Genetic studies have revealed that a small number of evolutionarily conserved pathways are 
used repeatedly in different contexts to control many cell fate decisions in all animals during 
their development. These include:  the Bone morphogenetic protein (Bmp), Wnt, receptor 
tyrosine kinase, Notch and Hedgehog (Hh) pathways (Huangfu and Anderson, 2006). However, 
gene duplications and the increase of organism complexity during evolution led to increased 
numbers of pathway components and their divergent functions.  
 
 
3.1 Hedgehog (Hh) signalling 
 
The Hh signalling cascade is one of the key pathways for mammalian development. The Hh 
gene was first identified in a Drosophila genetic screening by Christiane Nüsslein-Volhard and 
Eric Wieschaus in 1980 and was observed to be important for embryonic segmentation and 
imaginal discs specifications in Drosophila (Nüsslein-Volhard and Erik Wieschaus, 1980; Basler 
and Struhl, 1994; Mohler, 1988; Tabata et al., 1992). Hh is conserved from insects to 
mammals and has been studied in greatest depth in Drosophila, in which forward genetic 
screens allowed identification of  various components of the Hh signalling pathway (Hooper 
and Scott, 2005; Huangfu and Anderson, 2006). However, recent genetic studies have defined 
a surprisingly large number of proteins required for Hh signalling in vertebrates and mammals 
that have no apparent role in Drosophila Hh signalling.  
 
 
3.1.1 Mechanisms of Hh signal transduction in mammalian tissues 
 
Vertebrate Hh genes were first reported in 1993 across different species (fish, chick and 
mouse) by several groups (Echelard et al., 1993; Krauss et al., 1993; Riddle et al., 1993; Chang 
et al., 1994; Roelink etal., 1994). The obvious difference between invertebrates and 
vertebrates is that the genes encoding the specific Hh pathway components have been 
duplicated during vertebrate evolution (Kumar et al., 1994, Meyer and Schartl, 1999; Mazet 
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and Shimeld, 2002). Three Hh homologs, Sonic hedgehog (Shh), Indian hedgehog (Ihh) and 
Desert hedgehog (Dhh) have been identified in mammals. Dhh is most closely related to the 
Drosophila Hh protein and regulates spermatogenesis whereas Shh and Ihh are more closely 
related to each other (90% amino acid identity) than to Dhh (80% amino acid identity). Shh 
and Ihh also play essential roles during embryonic development (Echelard et al., 1993). All 
three Hh proteins are synthesized as a precursor of ∼45-kDa which undergoes auto-processing 
to generate a ∼19-kDa amino-terminal fragment (Hh-N). The Hh-N fragment is activated after 
two post-translational modifications: covalent attachment of a cholesterol moiety to the 
carboxy-terminus and palmitoylation at the amino-terminus (Lee et al., 1994; Porter et al., 
1995; Porter et al., 1996; Li et al., 2006; Li et al., 2011). These lipid modifications are crucial 
and contribute to the mobility and full signalling capacity of Hh proteins (Lewis et al., 2001; 
Chen et al., 2004). 
Secretion of Hh ligands induces various effects dependent on the cellular context. Hh can act 
as an on-off switch that regulates the fate of immediately adjacent cells. Alternatively, Hh can 
act as short-range morphogen over a distance of around 10-15 cell diameters or as long-range 
morphogen spanning over more than 100 cell diameters (Ingham and Hidalgo, 1993, Stone et 
al., 1996; Strigini and Cohen, 1997; Huangfu and Anderson, 2006). The Hh signalling cascade is 
initiated upon binding of a Hh ligand to its receptor Patched (Ptch), a protein with 12-
transmembrane spanning domains (Fig. 1). There are two Ptch homologs in mice, Ptch1 and 
Ptch2. Ptch1 and Ptch2 are differentially expressed during development suggesting specific 
roles for each protein. Ptch1 is more widely expressed during embryonic development and in 
mouse and human it is known as a tumour suppressor. The function of Ptch2 however has not 
been fully clarified inspite of loss-of-function studies. A recent study suggests that Ptch2 may 
also act as a Hh receptor and modulates signalling in various cellular environments (Smyth et 
al., 1999; Rahnama et al., 2004, Lee et al., 2006; Eriken Nieunenhuis???).  
Smoothened (Smo) a 7-transmembrane spanning protein is repressed by Ptch1 in the absence 
of the Hh-ligand. In the presence of high levels of Hh ligand, Ptch1 inhibition is released and 
Smo transduces the signal to the downstream Glioma-associated family of zinc finger 
transcription factors Gli1, Gli2 and Gli3. The precise mechanism by which Smo activates this 
cascade remains unclear. It is known that a conformational change of Smo protein and its 
translocation to the primary cilium are the two critical events for activation of the Hh pathway  
              Introduction 
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Figure 1: Scheme of the Hh pathway in vertebrates and mammals. 
In the absence of Hh ligand (left) Ptch1 represses the transmembrane protein Smo; preventing the accumulation 
of Smo in cilia and turning off downstream signalling. Activation of Gli transcription factors is inhibited by a group 
of proteins: Sufu, Iguana (for zebrafish) and Cos2. Gli2 and Gli3 are processed (phosphorylated and cleaved) into 
a repressor form (GliR) in a cilia-dependent manner. The short form of Gli (GliR) accumulates in the nucleus and 
represses the transcription of target genes. In the presence of high levels of Hh ligand (right), Ptch1 inhibition is 
released; Smo is recruited to cilia and activates Gli proteins. The Gli proteins are no longer cleaved and full length 
Glis activate the transcription of Hh-target genes. Ptch1 (Patched1), Smo (Smoothened), Gli (Glioma-associated 
family of transcription factors), Sufu (Suppressor of Fused), p (phosphorylation), PKA (protein kinase A). 
(Modified after Huangfu and Anderson, 2006) 
 
in vertebrates (Zhao et al., 2007; Taipale et al., 2002). Smo controls both the activation of Gli 
transcription factors and the proteolytic processing event that generates a repressor form of 
Gli. However, this does not occur for all Gli proteins (Huangfu and Anderson, 2006). Gli3 and 
Gli2 are bifunctional and can be processed into a repressor or a transcriptional activator 
(Wang et al., 2000; Aza-Blanc et al., 2000). Gli1 cannot be proteolytically processed and is 
solely a transcriptional activator (Dai et al., 1999; Lee et al., 1997; Ruiz i Altaba, 1998). The 
three Gli proteins are characterised by a homologous zinc finger domain and have limited 
homology outside this region (Matise and Joyner 1999). Upon activation of the Hh pathway, 
the active form of the Glis (GliAct) induces the expression of target genes including Ptch1 and 
Gli1, which provide a negative (Ptch1) and a positive (Gli1) feedback for Hh signalling (Ruiz i 
Altaba et al., 2007; Wang et al., 2000; Pan et al., 2006; Litingtung et al., 2002; Bai et al., 2004).  
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3.1.2 Expression and function of Hh ligands during mammalian 
 development  
 
Hh ligands act as morphogens and regulate multiple developmental processes (Fig. 2). All 
mammalian Hh ligands have similar signalling capacities but exert different roles during 
development due to their diverse expression patterns (Ingham and McMahon, 2001; 
McMahon et al., 2003; Sagai et al., 2005; Varjosalo and Taipale, 2008).  
 
 
 
 
 
 
 
Figure 2: Temporal control of Hh expression and function during mammalian development. 
(Top) Embryo cartoons show regions of the Hh target gene expression depicted by the embryos. Ptch1 (blue) 
during mouse embryonic development. (Bottom) Bars show approximate embryonic stages when Shh, Ihh, 
and/or Dhh (color code in bottom left) control developmental processes in the indicated tissues or cell types. The 
embryonic stage is indicated by postcoital (dpc) (Varjosalo and Taipale, 2008; Ingham and McMahon, 2001). 
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Shh, the best characterised Hh ligand, is the most broadly expressed during mammalian 
development. Shh expression has been detected in the notochord, floor plate, limbs and 
many other developing organs (Huangfu and Anderson, 2006). Shh is an essential factor for 
patterning of the dorso-ventral axes as well as for the morphogenesis of different organs 
(Ingham and McMahon, 2001, McMahon et al., 2003; Varjosalo and Taipale, 2008). In 
contrast, Dhh expression and function is restricted to the regulation of spermatogenesis and 
development of the perineural sheath (Bitgood et al. 1996; Parmantier et al., 1996; Yao et al. 
2002; Wijgerde et al. 2005). Ihh expression is limited to a few tissues during development, 
including primitive endoderm (Dyer et al. 2001), gut (Ramalho-Santos et al., 2000; van den 
Brink 2007) and growth plates of the bones (Vortkamp et al., 1996; St-Jacques et al. 1999, 
Karp et al., 2000). Importantly, more than one ligand is often expressed in the same tissue and 
therefore, can act redundantly.  
Hh signalling also plays important roles beyond development and controls tissue maintenance 
and differentiation in adult organs (Varjosalo and Taipale, 2008), for instance in the 
gastrointestinal tract, pancreas, uterus, mammary gland and skin (St-Jacques et al., 1998; Oro 
at al. 2002; Ingham and McMahon, 2001; Varjosalo and Taipale, 2008).  
 
 
3.2 Structure and function of mammalian skin 
 
The skin is the only organ in mammals which is in direct contact with the surrounding milieu 
and forms an effective barrier between the organism and the environment. Its’ functions are 
to protect the body against pathogens, UV radiation, chemical and mechanical stress as well 
as the regulation of temperature, water and electrolyte balance (Wokalek, 1992, Chuong et 
al., 2002; Blanpain and Fuchs, 2006; Segre 2006). In addition, animals can perceive their 
environment through the tactile sense of the skin.  In mammals, the skin is the largest organ 
and consists of the epidermis, dermis and subcutaneous tissue, the hypodermis (Fig. 3). The 
subcutis is the fat tissue below the dermis composed of adipocytes (Alberts, 2008; Montagna 
and Parakkal, 1974).  The dermis is a mesenchymal connective tissue, which underlies the 
epidermis. It is composed of fibroblasts and extracellular matrix (ECM) components (e.g. 
collagen  and elastic fibers) and provides stability and nutrients for the epidermis. The cross 
talk between dermis and epidermis is important for proliferation and morphogenesis of the 
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epidermal compartment. The epidermis, the outer most layer of the skin, is separated by a 
basement membrane from the dermis and is composed of two major compartments,  the 
interfollicular epidermis (IFE) and the pilosebaceous unit (Fig. 3, 4). The epidermis is a 
stratified squamous epithelium, composed of several layers. The basal layer of IFE consists of 
the proliferating and transit amplifying cells giving rise to suprabasal differentiated cells of the 
spinous, granular, and cornified layer (Fig.3). The pilosebaceous unit is made of hair follicles 
(HFs) and sebaceous glands (SGs). 
 
 
 
 
Figure 3: Skin morphology and structure of the interfollicular epidermis (IFE). 
(A) Haematoxylin- and eosin-stained section of the dorsal skin of an adult mouse demonstrating epidermis (E), 
dermis (DE), and subcutis (SC). The epidermis consists of different compartments such as the interfollicular 
epidermis (IFE), Hair follicles (HF), bulge (B) and sebaceous glands (SG) (B) The IFE is composed of different 
layers: basal layer (BL), spinous layer (SL), granular layer (GL) and cornified layer (CL) (Niemann and Watt, 2002; 
modified after Fuchs and Raghavan, 2002).  
 
The HF is composed of the outer root sheath (ORS), companion layer, inner root sheath (IRS), 
hair shaft and the rapidly proliferating matrix cells in the hair bulb, which give rise to the 
different hair lineages (Fig. 4) (Niemann and Watt, 2002; Blanpain and Fuchs, 2006; 
Shimomura and Christiano, 2010). Continuous renewal of the HF throughout life requires 
multipotential SC. The best characterised Hair follicle stem cell (HFSC) compartment is the 
bulge region which is established within the permanent part of the HF (Nowak et al., 2008). 
The SG is an epidermal appendage associated with HFs. The SG consists of an undifferentiated 
              Introduction 
25 
 
layer of keratinocytes at the periphery of the gland and differentiated sebocytes in the center. 
(Fig. 4) (Niemann, 2009; Schneider and Paus, 2009). One important feature of the mature 
sebocytes is the accumulation of lipid droplets. Once mature sebocytes burst, the lipid 
containing sebum is delivered via the sebaceous duct to the hair channel and surface of the 
skin. The secreted sebum lubricates the hair channel and the surface of the skin. It also 
protects the skin against pathogens and environmental stress factors (Thody and Shuster, 
1989; Schneider and Paus, 2009). Therefore, the proper function of SGs is crucial for 
maintenance of the skin barrier. Furthermore, malfunctions of the SGs are associated with 
diseases including Acne vulgaris and cancers (Zouboulis, 2004). 
 
 
Figure 4:  Structure of the pilosebaceous unit. 
(A) Haematoxylin- and eosin-stained whole mount of mouse tail skin demonstrating HFs, SGs and the bulge 
region (B) of the HF. (B) Schematic drawing of the SG illustrating three regions: basal cell layer (PZ), partially 
mature sebocytes (MZ) and fully mature sebocytes (NZ). (C) Haematoxylin- and eosin-stained section through the 
base of a growing follicle. (D) Schematic drawing of the HF consisting of different cell layers: outer root sheath 
(ORS), companion layer, inner root sheath (IRS), hair shaft, matrix containing HF progenitor cells and the dermal 
papilla (DP), a specialized mesenchymal component embedded in the hair bulb which induces HF proliferation. 
(Niemann and Watt, 2002; Schneider and Paus, 2009). 
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3.3 Hedgehog signalling during skin development and regeneration 
 
During skin development, a complex signalling network controls the morphogenesis and 
regeneration of each epidermal compartment. Hh signalling is one of the essential pathways 
during skin development and homeostasis (St-Jacques et al., 1998; Oro and Higgins, 2003). In 
mammalian skin, Shh is expressed in the matrix of the hair bulb and promotes cell 
proliferation and cyclic hair regeneration (Fig. 5A, G, H, I) (Oro at al., 2001; St-Jacques et al., 
1998; Chiang et al., 1999; Sato et al., 1999; Wang et al., 2000; Oro and Higgins, 2003). During 
early skin development, expression of Shh in placodes of the HF and expression of Ptch1, Smo, 
Gli1 and Gli2 in both the epithelial and dermal compartment suggests Shh signalling activity in 
cell types derived from both compartments (Fig. 5A-F). (Oro et al., 1997; St-Jacques et al., 
1998, Oro and Higgins, 2003). Lower levels of Ptch1, Smo, Gli1 and Gli2 expression were also 
detected in keratinocytes and in the dermis of the interfollicular region (Fig. 5A-F) (Oro et al., 
1997; St-Jacques et al., 1998). However, the function of the Hh pathway in the IFE has not 
been elucidated yet. 
 
 
 
 
 
 
 
 
Figure 5:  Expression pattern of Shh and Hh pathway components during HF morphogenesis and hair 
regeneration. 
(A-F) Expression of Shh (A), Ptch1 (B), Ptch2 (C), Gli1 (D), Gli2 (E), and Gli3 (F) at E18.5 in wild-type skin. 
(G-H) Shh expression in the cyclic, adult HF during hair development. (I) Shh expression in late anagen HFs. Bulge 
(BU), hair germ (HG), dermal papilla (DP), (Mill et al., 2003; Blanpain and Fuchs, 2006 review; Levy et al., 2007). 
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3.4 Ihh signalling during epidermal development 
 
Previous studies indicate that Ihh is expressed in differentiated sebocytes in murine and 
human skin (Niemann et al. 2003; Takeda et al., 2006; Lo Celso et al., 2008; Bonfanti et al., 
2010). In addition, a nuclear accumulation of Gli1 was observed in undifferentiated sebocytes 
at the periphery of the SG (Fig. 6) (Niemann et al. 2003). In vitro studies also indicate 
increased amounts of Ihh protein in differentiated human sebocytes (SZ95 cell line) and a 
nuclear accumulation of Gli1 and Gli2 in undifferentiated sebocytes. This increase in Gli 
expression correlates with proliferation of undifferentiated cells (Niemann et al., 2003; 
Takeda et al., 2006; Lo Celso et al., 2008). The data suggest a paracrine mechanism of Ihh 
signalling in modulating proliferation of sebocyte progenitors in vitro (Niemann et al. 2003). 
More detailed analyses indicated that components of the Hh pathway including Ihh, Ptch1, 
Smo, Gli2 and Gli3 are up-regulated upon differentiation in human sebocytes (Sequaris et al., 
unpublished data). The up-regulation of a Gli reporter construct upon sebocytes 
differentiation shows that not only components of the Hh pathway but also Hh signalling 
activity increases during sebocyte differentiation (Sequaris et al., unpublished data).  
 
 
 
 
  
Figure 6:  Expression of Gli1 in the SG of mouse skin.  
Immunostaining for Gli1 protein (green) in whole mounts of wild type tail epidermis. Scale bars 50µl. (Niemann 
et al., 2003) 
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Gain and loss of function studies of components of the Hh pathway support the concept that 
Hh signalling plays an important role for SG differentiation (Table 1) (Niemann, 2009). For 
instance, ectopic activation of Hh signalling by overexpression of a gain-of-function mutant of 
the Smo receptor, K5-SMOM2, increases size and number of sebaceous glands (Fig. 7B) (Allen 
et al. 2003). In addition, constitutive Gli2 expression in the basal layer of all epidermal 
compartments (K5-Gli2) induces formation of ectopic sebaceous ducts and highly branched 
SGs not only in association with HFs but also with the IFE (Fig. 7D) (Gu and Coulombe 2008). In 
contrast, inhibition of Hh signalling in the skin by a dominant-negative form of Gli2 (K5-
Gli2∆C4) leads to suppression of sebocyte development (Fig. 7C) (Allen et al. 2003). Taken 
together, these data led to the hypothesis that Ihh signalling could be an important mediator 
of sebocyte differentiation and SG formation in mammals.  
 
 
 
 
 
 
 
Figure 7:  Modification of SG formation in transgenic mouse models. 
(A) Wild type skin. The black arrows indicate HF associated SGs. (B) K5-SMOM2 transgenic (tg) mice expressing a 
constitutive active SMO mutant in keratinocytes, indicates increased number of SGs. (C) K5-Gli2∆C4 tg mice with 
a constitutively expressed dominant-negative Gli2 allele in keratinocytes do not develop SG. (D) K5-Gli2 tg mice 
with constitutive expression of Gli2 develop prominent sebaceous ducts and additionally highly branched SGs 
(Allen et al. 2003; Gu and Coulombe 2008).  
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3.5 Hh signalling in skin cancer 
 
Aberrant regulation of the Hh pathway is implicated in several human developmental 
abnormalities and diseases including cancer. The first link between the Hh pathway and 
cancer was discovered in humans in 1992 (Gailani et al., 1992). Inherited loss of function 
mutations in the human PTCH1 gene were identified as the underlying cause of the Nevoid 
Basal Cell Carcinoma Syndrome (NBCCS), also called Gorlin syndrome (Hahn et al., 1996; 
Johnson et al., 1996). The NBCCS causes developmental defects within different organs such 
as the nervous system, eyes, bones, endocrine system and skin. Also sporadic Basal Cell 
Carcinoma (BCC) are frequently caused by inactivating mutations in PTCH1 or to a lesser 
extent, by activating mutations in SMO, both causing a constitutive activation of the Hh 
pathway (Hahn et al. 1996; Johnson et al. 1996; Gailani et al. 1996; Xie et al., 1998; Pasca di 
Magliano and Hebrok, 2003). BCC is the most common human cancer among Caucasians 
(Epstein, 2008 review). The main trigger of BCC is exposure of the skin to ultraviolet (UV) light. 
People with fair skin are especially at risk.  
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Many transgenic mouse models exist for BCC or BCC-like lesions. These include mice with 
reduced levels of Ptch1 (Ptch+/-, Ptch fl/fl:K14, Ptch fl/fl:K6), an activated form of human SMO 
(K5-SMOM), epidermal overexpression of mouse Shh (K14-Shh), Gli2 (K5-Shh) and mouse and 
human Gli1 (K5-Gli1; K14-GLI1) mimic BCC or BCC like lesions  (Table 2) (Goodrich et al., 1997, 
Hahn et al., 1998; Xie et al., 1998; Grachtchouk et al., 2003; Oro et al. 1997, Grachtchouk et 
al., 2000, Dahmane et al., 1997; Nilsson et al., 2000; Oro and Higgins, 2003).  
In addition to BCC Hh pathway activity is also involved in the pathogenesis of other skin 
cancers including Squamous Cell Carcinoma (SCC) (Asplund et al., 2005; Snijders et al., 2005; 
Wakabayashi et al., 2007), Merkel cell carcinoma (Brunner et al., 2010), Basal Follicular 
Hamartoma (BFH) (Svärd et al., 2006), tumour of the follicular infundibulum (TFI) 
(Grachtchouk et al., 2011) and Sebaceous adenoma (Niemann et al., 2003). 
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3.5.1 Hh signalling activity in sebaceous tumours  
 
Mice expressing N-terminally truncated Lef1 (∆NLef1), which blocks β-catenin signalling, in 
the basal layer of the epidermis (K14∆NLef1 transgenics) develop spontaneous sebaceous 
tumours including sebaceous adenoma and sebeceoma (Niemann et al. 2002). In humans 
sebaceous tumours are relatively rare benign age-related tumours. Lesions are usually located 
on sun-damaged skin of the head and neck area (LeBoit, 2006). One third of human sebaceous 
tumours are associated with mutations in Lef1 which impair Lef1 binding to β-catenin (Takeda 
et al., 2006).  
A previous study showed that treatment of K14∆NLef1 transgenic mice with the carcinogen 
DMBA induced high frequencies of sebaceous tumours in those mice (Niemann et al., 2007). 
The ∆NLef1 mutant appears to act as tumour promoter by preventing accumulation of the 
tumour suppressor p53. Analysis of sebaceous tumours of K14∆NLef1 transgenic mice 
revealed high expression of Ptch1 and Gli1. The increased Ptch1 RNA and protein levels and 
the nuclear localisation of Gli1 indicate that Hh signalling is activated in sebaceous tumours 
(Niemann et al., 2002, Niemann et al., 2003). Ihh is the prominent Hh ligand expressed in 
mature sebocytes of sebaceous tumours whereas no Shh and Dhh was detected. In human 
sebaceous adenoma high levels of IHH, PTCH1, GLI1 and GLI2 expression were also observed 
whereas SHH and DHH were not significantly expressed (Niemann et al., 2003). In contrast, 
Ihh protein was not detectable in Pliomatricomas which are benign skin tumours derived from 
the HF, indicating a specific function of Ihh during sebaceous tumour formation. Together 
these data suggest an involvement of Ihh signalling during epidermal lineage selection in 
normal skin and sebaceous tumours. 
 
 
 
 
 
 
 
              Introduction 
32 
 
3.5.2  Hh signalling and p53  
 
p53 is one of the most well known tumour suppressor genes in mammals. It is mutated in 
majority of human cancers (Vogelstein et al., 2000). Its importance can be explained by the 
fact that it acts as a transcriptional regulator in a number of processes, which protect the 
organism against cell damage and uncontrolled proliferation. Thus, it is involved in cell-cycle 
control, apoptosis and maintenance of genetic stability (Vogelstein et al., 2000; Vousden and 
Lane, 2007).  Undamaged cells are characterised by low levels of p53 protein where it is 
efficiently ubiquitinilated and targeted for degradation by the proteasome. However upon 
hypoxia, radiation-induced DNA damage (UV, X-ray) and induction of proliferation, p53 
protein degradation is blocked resulting in a fast accumulation of the protein. p53 acts mainly 
as a transcription factor controlling a large number of genes, including the cell cycle inhibitor 
p21, several DNA repair genes (p53R2, XpC, XpG,)  and many regulators of apoptosis (BAX, Bcl-
2, Puma) (Polager and Ginsberg, 2009; Weinberg, 2007). 
Mutational analyses of p53 indicate that p53 is not a typical tumour suppressor gene. 
Surprisingly, p53 inactivation does not lead to lethality while the inactivation of most tumour 
suppressor genes has profound developmental defects and results in lethality. Mice lacking 
p53 (p53-/-) show largely normal development but have a shorter life span and develop 
cancer (lymphoma and sarcoma) before reaching 10 months of age (Jacks et al., 1994). A 
closer examination Trp53 knockout mice (p53-/-) has however revealed that p53 negatively 
regulates proliferation and self-renewal of neural stem cells (Meletis et al, 2006). Recent 
studies on the production of induced pluripotent stem cells derived from somatic cells 
uncovered an even more general function of p53 in preventing cellular reprogramming and 
de-differentiation (Zhao and Xu, 2010, Puzio-Kuter and Levine, 2009). On the basis of these 
findings p53 has been suggested to contribute to the balance between tumour suppression 
and long-term cell proliferative potential, which is essential for the longevity of organisms 
with renewable tissues such as mammals (Vousden and Lane, 2007). 
Recent studies indicate that, in particular for stem cell biology, Hh signalling is involved in 
regulating p53. In humans and mice the level of Gli1 is critical in maintaining neural stem cell 
number (Stecca and Ruiz i Altaba, 2009). In addition, downregulation of Gli1 activity limits 
brain tumour formation by reducing the number of cancer stem cells (Clement et al., 2007; 
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Stecca and Ruiz i Altaba, 2009). This regulation depends on the interaction between the p53 
and Gli1. Mechanistically p53 blocks nuclear localisation, expression levels, and consequently 
the activity of Gli1.  Conversely, Gli1 represses p53 thereby establishing a sensitive balance 
between p53 and Gli1. Furthermore it was shown that stimulation of cerebellar granular 
neural precursor cells (GNP) with Shh promotes the accumulation and activity of the p53 
inhibitor Mdm2 (Malek et al., 2011). Studies in zebrafish also indicate that Shh signalling 
controls p53 activity, which is required for cell cycle exit of retinal cells and differentiation of 
photoreceptors (Prykhozhij, 2010).  
Previous studies have shown that p53 nuclear accumulation is increased in papilloma and SCC 
of wild-type mice, when induced by oncogenic Ras (Vousden et al. 2002). Interestingly, in 
sebaceous tumours induced in K14∆NLef1 transgenic mice the opposite trend was observed, 
nuclear p53 being significantly reduced (Niemann et al., 2007). Since in these tumours Ihh is 
up-regulated the question arises whether the unusual behaviour of p53 in sebaceous tumours 
is due to negative regulation by Hh signalling (Fig. 8). 
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Figure 8: Schematic view of sebaceous tumour development.  
The molecular mechanism which causes initiation of spontaneous sebaceous tumour in not clear yet, however 
chemical induction of H-Ras mutation is sufficient to induce sebaceous tumours in K14∆NLef1 transgenic mice. 
The ∆NLef1 specifies tumor type and prevents accumulation of p53 by acting as a tumour promoter. The Ihh 
signal is proposed to be produced by differentiated sebocytes in the sebaceous tumours and is suggested to be 
involved in the differentiation process in sebaceous tumour. 
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3.6 Aims of this study 
 
Many essential components of the Hh pathway, including the ligand Ihh, are expressed in 
mature sebocytes of SGs and sebaceous tumours in humans and mice. In vitro studies 
demonstrate that Ihh is involved in controlling differentiation and proliferation of sebocytes. 
However an in vivo function of Ihh for morphogenesis and homeostasis of the skin has not 
been identified yet. Therefore, the aims of this project are: 
 
• Generation and analysis of an epidermis-specific KO mouse model for Ihh. 
 
• Investigation of a potential function of Ihh signalling during skin development and 
epidermal homeostasis, focusing on sebocyte differentiation and SG formation  
 
• Determining the consequences of loss of epidermal Ihh for sebaceous tumour 
formation, as well as for development and progression of squamous skin tumours.  
 
• Unravelling the molecular mechanism of Ihh signalling in skin and skin tumours 
including an analysis of the relationship between Hh signalling and p53. 
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4  Materials and Methods 
 
4.1 Materials 
 
4.1.1 Chemicals, solvents, media and additives  
 
 Table 3: Chemicals and Reagents 
 
  
 Chemical  Supplier 
 
  
 Agarose (Star pure9 Starlab, Ahrensburg 
 Ampicillin  Fluka, Buchs, CH, Germany 
 Automation Buffer (10x) GenTex Inc., Germany 
 Bovine Serum Albumin (BSA) Sigma-Aldrich, Steinheim 
 BrdU (5-bromo-2’-deoxyuridine) Sigma-Aldrich, Germany 
 Cholera toxin Sigma-Aldrich, Germany 
 Collagen G Biochrom AG 
 Complete Mini protease inhibitor Roche, Mannheim 
 Deoxycholic Acid (DCA) Fluka, Buchs, CH 
 Diamidino-2-phenylindol (DAPI) Sigma-Aldrich, Steinheim 
 Diazabicycloloctan (DABCO) Sigma-Aldrich, Steinheim   
 7,12-dimethylbenz-[a]-anthracene (DMBA) Sigma-Aldrich, Steinheim 
 Dimethyl Sulfoxide (DMSO) Sigma-Aldrich, Steinheim 
 Dithiothreitol (DTT) Biochemika, Duesseldorf 
 D-MEM/Ham`s F12 Biochrome, Berlin, Germany 
 EDTA pH 8.0 (0.5M) Gibco, Germany 
 Epidermal Growth Factor (EGF) Biochrom, Berlin 
 Ethanol Roth, Karlsruhe 
 Ethidium bromide Amersham Biosciences, Uppsala, S 
 Ethylenediaminetetraacetic Acid (EDTA) Roth, Karlsruhe 
 Fetal Calf Serum (FCS) Biochrom, Berlin 
 Glycerol Roth, Karlsruhe 
 Glycine Roth, Karlsruhe 
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 HEPES Merck, Darmstadt 
 Hydrochloric acid (HCl) Fluka, Buchs, CH 
 Isopropanol Roth, Karlsruhe 
 Keratinocyte Growth Factor (KGF) Biochrom, Berlin 
 Kanamycin Fluka, Buchs, CH 
 MassRuler DNA Ladder, high range  Fermentas; Germany 
 MassRuler DNA Ladder, low range  Fermentas, Germany 
 Magnesium Chloride (MgCl2) Sigma-Aldrich, Steinheim 
 Methanol Roth, Karlsruhe 
 Milk powder Heirler, Radolfzell 
 MOPS (10x) Invitrogen, Karsruhe 
 Mowiol Calbiochem, Darmstadt 
 Mitomycin C Sigma, Aldrich Steinheim 
 Mowiol Calbiochem 
 NaCl Roth, Karlsruhe 
 Normal goat serum (NGS) Sigma-Aldrich Steinheim 
 NuPAGE Antioxidant Invitrogen, Karsruhe 
 NuPAGE LDS Sample Buffer Invitrogen, Karsruhe 
 NuPAGE MOPS SDS Running Buffer Invitrogen, Karsruhe 
 Optimem I Invitrogen, Karlsruhe 
 Paraformaldehyde (PFA) Merck, Darmstadt 
 Protease inhibitor cocktail tablets Roche, Mannheim 
 PBS Biochrom, Germany  
 PCR-Mastermix “Ready to load” Bio-Budget, Germany 
 Penicillin/Streptomycin Biochrom, Germany 
 Pertex Leica, Germany 
 PFA Merck, Darmstadt 
 Sebomed basal culture medium Biochrom, Berlin 
 Sodium Dodecyl Sulfate (SDS) Roth, Karlsruhe 
 Sodium chloride (NaCl) Roth, Karlsruhe 
 Sodium hydroxide (5M NaOH) Roth, Karlsruhe 
 SOC-Medium Invitrogen, Karlsruhe 
 12-O-Tetradecanoylphorbol-13-acetat (TPA) LC laboratories, USA 
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 Transfer buffer Invitrogen, Karlsruhe 
 Tris Roth, Karlsruhe 
 TritonX-100 Merck, Darmstadt 
 Trypsin/EDTA Biochrom, Berlin 
 Tween-20 Roth, Karlsruhe 
 Xylol  Roth, Karlsruhe 
 
 
 
4.1.2 Kits, devices and accessories  
 
 Table 4: Kits  Supplier 
 
 
 Pierce BCA Protein Assay Kit  Pierce Biotechnology, USA 
 QIAGEN Plasmid Purification Mini Kit Qiagen, Hilden 
 ECL Plus Western blotting detection reagent GE Healthcare, Germany 
 DeadEnd™ Fluorometric TUNEL System Promega, Germany 
 
 
 
 Table 5: Devices and accessories Supplier 
 
 Cameras: 
 Nikon eclips-E800 Nikon Instech Co, Japan 
 Nikon DMZ1200 camera Nikon Instech Co, Japan  
 Olympus U-TB190, 8M14203 Olympus GmbH, Japan 
 Leica DM 4000B  Leica Microsystems, Germany 
 Leica JVC 3-Chip-Kamera KY-F75U Leica Microsystems, Germany 
 
 Centrifuges 
 Refrigerated Microcentrifuge, 5415 R Eppendorf AG, Hamburg 
 Microcentrifuge, 5417 C Eppendorf AG, Hamburg 
 
 Films 
 Hyperfilm for Western Blots  Amersham, Biosciences, UK  
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 Gel electrophoresis and blotting systems 
 NuPage Novex high-performance pre-cast gels Invitrogen, Karlsruhe  
 XCell II, Blot Module Invitrogen, Karlsruhe 
 
 Heating blocks 
 Eppendorf Thermomixer compact Eppendorf AG, Hamburg 
 
 Incubators 
 Hereaus 6000 cell incubator Kendro Laboratory Products, Germany 
 
 Photometer 
 BioPhotometer plus  Eppendorf AG, Hamburg 
 
 Others 
 BioDoc Analyze  Biometra 
 Curix 60 developer  AGFA; Belgian 
 ECL Hyperfilm  Fermentas 
 Eppendorf Thermomischer kompakt  Eppendorf AG, Hamburg 
 Loading dye blue 6x  Fermentas, St. Leon-Rot  
 MagicMark-XP  Invitrogen, Karlsruhe 
 MasterMix (2,5x) PCR Mix  Eppendorf AG, Hamburg 
 NuPAGE Novex 4-12% Bis-Tris Mini Gels  Invitrogen, Karlsruhe 
 PowerPac Universal  Biorad, Germany 
 PageRuler Plus Prestained  Fermentas, St. Leon-Rot  
 Pressure cooker (2100-Retriver) Prestige Medical, France 
 SERVAGel TG10–Vertical,Tris-Glycine Gel Serva, Germany 
 Westram Clear Signal nitrocellulose-  
 Membrane Whatman Inc, Stanford, USA 
 Whatman Gel Blot paper  Schleicher & Schuell, Dassel  
 Xcell II Blot module  Invitrogen, Karlsruhe 
 Xcell SureLock Mini-Cell  Invitrogen, Karlsruhe 
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4.1.3 Media, solutions and buffers 
  
 Phosphate buffered saline (PBS, Instamed), Biochrom, Berlin 
 10x TAE: 
 0.9M Tris Ultra 
 0.89M Boric acid 
 20mM EDTA  
 pH 0.8 
 
 1% Ripa buffer (western blot): 
 150mM NaCl 
 25mM Tris.HCL pH 7.5 
 1% sodium deoxycholate 
 1 % NP-40 
  add 1 protease inhibitor cocktail tablet to 10ml WCE buffer 
  after determination of protein concentration 1mM DTT was added 
 
 Whole cell extract (WCE) buffer (western blot):  
 20mM HEPES 
 0.42M NaCl 
 0.5% NP-40 
 0.5% DCA 
 25% glycerol 
 0.2mM EDTA 
 1.5mM MgCl2 
  add 1 protease inhibitor cocktail tablet to 10ml WCE buffer 
  after determination of protein concentration 1mM DTT was added 
 
 10x TBS (western blot): 
 0,2M Tris Base 
 2M NaCl  
 pH 7.6 
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 1x TBS-T (western blot):   
 100ml 10x TBS 
 0.1% Tween 
 1M Tris-HCl 1M Tris Base 
  pH 7.5 
  1l ddH2O 
  
 Blocking solution (western blot):  
 1x TBS-T 
 5% Milchpulver 
  
 Glycine strip (western blot):  
 0,1M Glycine 
 20% SDS 
 pH 2.5 
 
 1 x Tris glycine running buffer (western blot):  
 25mM Tris 
 190mM Glycine 
 10 % SDS 
 
 1 x Tris glycine transfer buffer (western blot): 
 25mM Tris 
 190mM Glycine 
 20 % Methanol 
 
 NuPAGE Invitrogen (western blot): 
 2μl NuPAGE Reducing agent (10x) 
 5μl NuPAGE LDL Sample Buffer (4x) 
 13μl Sample  
  20μl ddH2O 
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 5 x Laemmli loading dye (western blot): 
 60mM Tris.HCL pH 6.8 
 10% Glycerol 
 2% SDS 
 5% s-mercaptoethanol 
 0.01% bromophenol blue 
 
 TNE buffer lysis buffer:  
 40mM Tris 
 150mM NaCl 
 10mM EDTA 
 pH 7.4 
 
 Keratinocytes medium  
 DMEM/Ham’s F12 medium (500ml) 
 Supplements:  
 100U/ml penicillin 
 100μg/ml streptomycin  
 1.8 x 10-4M (16.6 mg) adenine 
 2mM L-Glutamine 
 0.5µg/ml (0.25 mg) hydrocortison 
 10ng/ml (5 μg) EGF 
 10-5M cholera enerotoxin 
 5 µg/ml (2.5 mg) insulin 
 10 % FCS Gold (chelex-100 resin treated) 
  FCS was treated with Chelex-100 resin overnight at RT, pH 7.0 and strained 
 through a sterile filter prior to use 
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 J2/3T3 fibroblast medium supplemented with: 
 
 DMEM 
 100U/ml penicillin 
 100μg/ml streptomycin 
 10 % FCS 
 
 
 Lysis buffer (isolation of gDNA): 
  0.2M NaCl 
 0.1M Tris HCl pH 8,5 
 5 µM EDTA 
 0.2% SDS 
 8.4 ml dH2O 
  add 5U Proteinase K (20mg/ml) before use 
 
 Mowiol/DABKO:  
 4.8 g Mowiol 
 12 g Glycerin 
 12 ml H2O 
  stirr 3 - 4 h 
  add 24 ml 0.2 M Tris pH 8 
  heat to 50 °C and stir overnight 
  add 1.2 g DABKO (2,5%)  
 
 1M Tris-HCl: 
 1M Tris Base 
 pH 7.5 
   
 
 Blocking solution for BrdU-IF-staining on cells: 
 3g BSA 
 10ml FCS 
 5g Milk powder 
 10µl Tween-20 
  100ml 1x PBS 
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4.2  Mice 
 
To generate epidermal specific Ihh knockout mice (Ihh EKO) (K14Cre+/-//Ihh fl/fl) homozygous 
mice carrying a floxed Ihh gene (Ihh fl/fl) (Razzaque et al., 2005) were crossed with mice 
expressing Cre-recombinase under control of the human Keratin 14 promoter (K14Cre+/-) 
(Hafner, et al. 2004). To generate triple mutant, homozygous Ihh EKO mice were crossed with 
K14∆NLef1 transgenic mice (Niemann et al., 2002).  
The Ihh floxed mice have been used in studies of the role of Ihh in other organs (Kobayashi et 
al., 2005; Lee et al., 2006; Mao et al., 2010; van Dop et al., 2010; Kosinski et al., 2010; Ochiai 
et al., 2010).  
All mouse strains used were backcrossed or maintained on a C57BL/6 background.  
In this study K14Cre+/-//Ihh fl/fl and Ihh fl/fl littermates were analysed for development of 
postnatal skin and were also used in two-stage carcinogenic tumour experiment. 
The K14∆NLef1 /K14Cre+/-//Ihh fl/fl and K14∆NLef1/Ihh fl/fl were used for one-stage 
carcinogenic tumour experiment. For the number and genotype of animals which were used 
in this study see table 6, 7 and 8.  
 
4.2.1 Tumour studies in K14ΔNLef1 transgenic mice 
 
 
To induce sebaceous tumours, skin of 8-9 week old K14ΔNLef1/Ihh EKO and K14ΔNLef1 
littermates were treated once with a sub-critical threshold dose of 7,12-dimethylbenz-[a]-
anthracene (100nmol DMBA /200µl acetone) (DMBA, Sigma-Aldrich) or acetone vehicle. 4 
weeks after topical DMBA application tumours develop. DMBA induces point mutations at 
different genes, including codon 61 of the proto-oncogene H-Ras (in K14ΔNLef1/Ihh EKO 
background). With special safety precautions the solution was applied onto the skin of the 
shaved back of anaesthetized mice. Scoring of tumours was carried out once a week for up to 
50 weeks after tumour initiation. For the number and genotype of animals which were used in 
this study see table 7 and 8  
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4.2.2 Two-stage skin carcinogenesis experiment 
 
 
To induce squamous tumours (papilloma and SCC) (Sundberg et al., 1997; Abel et al., 2009), 
skin of 8-9 week old Ihh EKO and Ihh fl/fl control littermates were treated once with a sub-
critical threshold dose of 7,12-dimethylbenz-[a]-anthracene (100nmol DMBA /200µl acetone) 
(DMBA, Sigma-Aldrich) or acetone vehicle. One week later animals received the tumour 
promoter TPA (12-O-Tetradecanoylphorbol-13-acetat, LC Laboratories) (6nmol/200µl acetone, 
or acetone vehicle only, three times per week for 25 weeks. Under special safety precaution 
the solution was applied onto the skin of the shaved back of anaesthetized mice. Scoring of 
tumours was carried out one a week for up to 50 weeks after tumour initiation. For the 
number and genotype of animals which were used in this study see table 7 and 8 
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       Table 6: Mice used in this studies 
Genotype number 
(n) 
Treatment Experiment 
Ihh fl/fl 8-15 
each 
stage 
___  
Studies for postnatal skin 
development (P0-P10) 
K14Cre+/-//Ihh fl/fl 8-15 
each 
stage 
___ 
 
       Table 7: Mice used in this studies, first set of tumour experiment 
Genotype number 
(n) 
Treatment Experiment 
Ihh fl/fl 19 DMBA/TPA Two-stage carcinogenic 
experiment 
K14Cre+/-//Ihh fl/fl 20 DMBA/TPA Two-stage carcinogenic 
experiment 
K14Cre+/-//Ihh fl/fl 5 TPA/Acetone Two-stage carcinogenic 
experiment 
Ihh fl/fl 4 DMBA/Acetone Two-stage carcinogenic 
experiment 
K14Cre+/-//Ihh fl/fl 5 DMBA/Acetone Two-stage carcinogenic 
experiment 
K14∆NLef1/hh fl/fl 17 DMBA One-stage carcinogenic 
experiment 
K14∆NLef1/K14Cre+/-//Ihh fl/fl 19 DMBA One-stage carcinogenic 
experiment 
K14∆NLef1/hh fl/fl 4 Acetone One-stage carcinogenic 
experiment 
K14∆NLef1/K14Cre+/-//Ihh fl/fl 5 Acetone One-stage carcinogenic 
experiment 
 
       Table 8: Mice used in this studies, second set of tumour experiment 
Genotype number 
(n) 
Treatment Experiment 
Ihh fl/fl 31 DMBA/TPA Two-stage carcinogenic 
experiment 
K14Cre+/-//Ihh fl/fl 33 DMBA/TPA Two-stage carcinogenic 
experiment 
K14∆NLef1/hh fl/fl 17 DMBA One-stage carcinogenic 
experiment 
K14∆NLef1/K14Cre+/-//Ihh fl/fl 17 DMBA One-stage carcinogenic 
experiment 
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4.3  Molecular Biology 
 
Standard methods of molecular biology were performed according to Sambrook and Russell 
(Sambrook and Russell, 2001; Celis, 2006) unless stated otherwise. 
 
 
4.3.1  Genotyping and efficiency of deletion 
 
Genotyping was performed by PCR on DNA extracted from tail biopsies using customised 
primers. PCR analysis on genomic DNA from split epidermis was performed to determine the 
efficiency of deletion of the floxed region in Ihh locus in the presence of keratin 14-driven Cre.   
 
 
4.3.2 Isolation of genomic DNA (gDNA) 
 
Tail biopsies of 3-week of mice were incubated in lysis buffer containing 0.2M NaCl, 0.1M 
Tris/HCl, PH8,5; 5µM EDTA; 0,2% SDS and 100µg/ml proteinase K (Sigma [39U/mg]) for 2-3 
hours at 55°C. After a centrifugation step, 2 volumes isopropylalcohol were added to the 
supernatant to precipitate gDNA. 150µl H2O (DNase free) was added to the pellet and 
subsequently, gDNA was dissolved O/N at RT. 
 
 
4.3.3  Polymerase Chain Reaction (PCR) for genotyping 
 
PCR (Mullis et al., 1987; Saiki et al., 1988) was used to amplify DNA fragments and genotype 
mice for the presence of floxed alleles and/or transgenes with customized primers listed in 
Table 9.  
All amplifications were performed in a total reaction volume of 25μl, containing a minimum of 
50ng template DNA, 5-25pmol of each primer, 25μM dNTPs Mix, 1U of RedTaq DNA-
polymerase and 1xRedTaq Reaction buffer. For genotyping Eppendorf MasterMix and RedTaq 
ReadyMix PCR kit with MgCl2 (Sigma) was used. 
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Standard PCR programs started with 5-8min denaturation at 95°C, followed by 30-32 cycles 
consisting of denaturation at 94°C for 30sec,  annealing at oligonucleotide-specific 
temperatures for 30-60 sec and elongation at 72°C for 30-45 sec and a final elongation step at 
72°C for 5-10 min. Based on the number of specific nucleotides in the primer, the following 
formula was used to estimate the melting temperature of primers: Tm=2(A+T)+4(G+C). All PCR 
reactions carried out either in T-Gradient Thermocyler or Personal Thermocycler (Biometra). 
PCR amplification products were analysed by agarose gel electrophoresis. PCR-amplified DNA 
fragments were applied to 2% (w/v) agarose gels (1x TAE electrophoresis buffer, 0.5mg/ml 
ethidium bromide) and electrophoresed at 120-200V. 
 
 
Table9: Oligonucleotides used for genotyping 
Mouse strain Primer Oligonucleotide (5´3´) T-Annealing [°C] 
Ihh floxed  
(Razzaque et al., 2005) 
fllhh-for-Lanske   5´-AGC ACC TTT TTT CTC GAC TGC CTG-3´ 68 
fllhh-rev-Lanske  5´-TGT TAG GCC GAG AGG GAT TTC GTG-3´ 68 
K14Cre 
(Hafner, et al., 2004) 
SC1-for 5´-GTC CAA TTT ACT GAC CGT ACA C-3´ 59 
SC3 -rev 5´-CTG TCA CTT GGT CGT GGC AGC-3´ 59 
K14∆NLef1 
(Niemann et al., 2002) 
dNLef1-for 5´-TGT CCC TTG TAT CAC CAT GGA CC-3´ 49 
dNLef1-for 5´-CCA AAG ATG ACT TGA TGT CGG CT -3´ 49 
All primer sequences are displayed in 5´-3’ order. Primer orientation is designated “sense” when coinciding 
with transcriptional direction. All primers were purchased from MWG, Germany. 
 
 
4.3.4  PCR anaylsis for efficiency of deletion 
 
PCR analyses were performed to amplify DNA fragment and genotype mice for the deletion of 
exon1 in floxed alleles to examine the Cre activity and its specific expression in the skin of 
Ihh EKO mice with customised primers listed in Table 10.  
All amplifications were performed in a total reaction volume of 25μl, containing a minimum of 
50ng template DNA, 5-10pmol of each primer, 25μM dNTPs Mix, 1U of RedTaq DNA-
polymerase and 1xRedTaq Reaction buffer. For deletion PCRs, RedTaq ReadyMix PCR kit with 
MgCl2 (Sigma) was used.  
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Standard PCR programs started with 4 min denaturation at 95°C, followed by 30 cycles 
consisting of denaturation at 95°C for 30 sec, annealing at oligonucleotide-specific 
temperatures (68°C) for 45 sec and elongation at 72°C for 80 sec and a final elongation step at 
72°C for 7 min. PCR reactions carried out either in T-Gradient Thermocyler or Personal 
Thermocycler (Biometra). PCR amplification products were analysed by agarose gel 
electrophoresis. PCR-amplified DNA fragments were applied to 1% - 3% (w/v) agarose gels (1 x 
TAE electrophoresis buffer, 0.5mg/ml ethidium bromide) and electrophoresed at 120-200V. 
 
 
 
Table10: Oligonucleotides used in PCR analysis for efficiency of deletion 
Mouse strain Primer Oligonucleotide (5´3´) T-Annealing [°C] 
 
K14Cre/Ihh fl/fl 
 
PK-Ihh-for-1-20    5´-CCG CAG ACG GCA GCA GCT CC-3´ 68 
PK-Ihh-For-56-77   5´-TGC TAA CCG CGG GTC CCT TCA G-3´ 68 
fllhh-rev-Lanske  5´-TGT TAG GCC GAG AGG GAT TTC GTG-3´ 68 
All primer sequences are displayed in 5´-3’ order. Primer orientation is designated “sense” when coinciding 
with transcriptional direction. All primers were purchased from MWG, Germany. 
 
 
4.3.5  DNA sequencing 
 
Genomic DNA was sequenced for Ihh exon1 deletion using an ABI Big dye terminator 
sequencing Kit (Applied Biosystems) according to the manufacturer’s instructions. The 
fluorescently labelled DNA was analysed with an ABI Prism3730 DNA analyser (Applied 
Biosystems). 
 
4.4  Protein biochemical methods 
 
4.4.1  Protein extraction from skin and skin tumours  
 
Skin or tumour tissue were lysed in 1-3ml of 1x Ripa lysis buffer supplemented with Complete 
Mini protease inhibitor cocktail (Roch) (10ml 1x Ripa buffer 1 tablet of Complete Mini  
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protease inhibitor). Skin and tumour lysates were generated by homogenising the tissue by a 
mixer mill (Qiagen) for 3-5 min at 30Hz. Lysates were incubated for 30 min on ice followed by 
30 min centrifugation at 13.500rpm, 4°C. The supernatants containing protein were 
transferred into new eppendorf tubes and after addition of DTT stored at -80°C and -20°C. 
 
 
4.4.2  Protein quantification by Biuret protein assay 
 
The protein concentration of the lysates was quantified by the bicinchoninic acid (BCA) 
method using the Pierce BCA Protein Assay Kit (Pierce Biotechnology, Rockford USA) 
according to the manufacturer’s instructions. This method is based on a two step detection 
system. In alkaline environment proteins form complexes with Cu2+ ions there by reducing 
them to Cu1+ ions (biuret method). Subsequently the reduced Cu1+ ions form a soluble 
purple complex with bicinchoninic acid (BCA) that has a maximal absorbance at 562nm. For 
the quantification of the protein concentration, samples were diluted 1:10. Applying the 
protocol, 10μl of the diluted sample as well as 10μl of eight BSA samples with known 
concentrations (0, 25, 125, 250, 500, 750, 1000, 1500 up to 2000μg/ml) for the standard curve 
were incubated with 200μl supplied BCA-working solution and incubated for 30 min at 37°C in 
96 well plates (TPP, Trasadingen, CH). The absorbance of the reaction product was measured 
by an Immuno Reader NJ-2000 (InterMed Inc., Cambridge USA) at 578nm. Each lysate was 
quantified as triplicates. The standard curve was made by plotting the absorbance of the BSA 
standards against their concentration (Fig. 9). The resulting equation of the standard curve 
was then used to calculate the unknown protein concentrations of the analysed samples. 
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Figure 9: Standard curve for determining unknown protein concentrations.  
Absorbance of BSA standards was plotted against their concentration. The corresponding linear equation was 
used to calculate the protein concentration in the samples. 
 
 
4.4.3  SDS-polyacrylamide-gel-electrophoresis (SDS-PAGE) 
 
Denaturised proteins were separated according to molecular mass via SDS polyacrylamide-
gelelectrophoresis (Laemmli, 1970). Samples were dissolved in 1x SDS-sample buffer (NuPAGE 
Invitrogen or Laemmli Loading Dye) incubated for 5 min at 92°C. 2-20μg of protein was loaded 
on the gels, which were separated at 200V per gel for an appropriate time (60-80min) in 
1xSDS running buffer (1x MOPS Running Buffer with 500μl NuPAGE Antioxidant). Depending 
on the molecular mass of the proteins of interest, commercially available gels 4-12% 
acrylamid and gradient gels (4-12% gradient Bis-Tris Gels, Invitrogen) were used. In addition, 
5μl PageRuler Plus Prestained Plus and 2μl and MagicMark XP were applied.  
The gel is then used for protein transfer to a nitrocellulose membrane. 
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4.4.4  Western blot analysis (WB) 
 
Western blot analysis is a method for detection of particular proteins using antibodies that are 
specific for the target protein. For this purpose, separated proteins were transferred to a 
methanol-activated nitrocellulose membrane “Westran Clear Signal PVDF membrane”, using a 
wet electorblot apparatus (Xcell Surelock Mini-Cell, Invitrogen, Karlsruhe) and commercially 
available 1x transfer buffer (Invitrogen). PVDF membrane was equilibrated 5min in methanol 
and subsequently 5-10 min in transfer buffer. Protein transfer was executed at 30V for 60-80 
min. Non-specific binding sites of the membrane were blocked for 1-2 h at RT either with 5% 
milk powder /1xTBS-T for both p53 and SCD1. In order to detect p53 and SCD1, total protein 
levels were incubated at O/N at 4°C with primary antibody (Table 11) diluted in 5% milk 
powder/1xTBS-T. After three 10 min wash steps in 1xTBS-T the membranes were incubated 
for 1-2h with the appropriate horseradish peroxidase (HRP) conjugated lgG secondary 
antibody (Table 12), also diluted in 5% milk powder/1xTBS-T.  After washing the membrane 
again three times for 10min in 1x TBS-T immuno-reactive proteins were visualised using ECL 
Plus Western blotting detection reagent (GE Healthcare) according to the manufacturer’s 
instructions and exposing the blot to ECL Hyperfilm. This detection system is based on the 
chemoluminescent oxidation of luminal catalysed by the peroxidase reaction in the presence 
of peroxide. Detection was repeated with different exposure times.  
 
 
4.4.5 Membrane stripping to detect housekeeping proteins  
 
To control if equal amounts of protein were blotted, detection of an endogenous loading 
control (here: α tubulin or GAP-DH) was performed. In order to reprobe the membrane it was 
incubated with glycine-strip for 1h at RT on shaker. Then it was washed two times in TBS-T to 
detach the previously bound antibodies. Afterwards, the membrane was washed and 
incubated in 1M Tris HCl for 10min. After three wash steps for 10min in TBS-T the protein 
detection was performed escribed in (4.3.5).  
Quantification of the bands was performed by selecting the area, means gray value  
and integrated density functions of the ImageJ software (http://rsb.info.nih.gov/nih-image), 
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on a grayscale picture. To obtain the relative signal intensity for each test sample band, the 
intensity values were divided to their respective GPA-DH or α-Tubulin band values. 
 
 
 
   Table 11: Primary antibodies used for WB 
Antibody Host Dilution Reference 
SCD1 (S-15) goat 1:400 Santa Cruz  
p53 mouse IgG1 1:1000 Cell Signaling 
GAP-DH rabbit 1:3000 Abcam 
a-Tubulin mouse IgG1 1:5000 Merck 
 
 
   Table 12: Secondary antibodies used for WB 
Antibody Dilution Reference 
HRP-conjugated anti-goat IgG 1:2500 GE Healthcare 
HRP-conjugated anti-mouse IgG 1:4000 GE Healthcare 
HRP-conjugated anti-rabbit IgG 1:3000 GE Healthcare 
 
 
 
4.5 Tissue Analysis 
 
Mice were sacrificed and tail and back skin or tumour tissue was dissected as described 
previously (Paus et al., 1999). 1h before sacrifice, all mice received a single IP injection of 100-
150mg/kg BrdU (Owen and Watt, 2001). Skin tumours and dorsal skin sections were 
harvested. Tissue was either fixed directly in 4% formaldehyde 2h at RT for paraffin 
embedding or stored at -80°C embedded in tissue Tec OCT (tissue freezing medium, Sakura) to 
perform cyrosections. Additionally, samples were directly transferred into liquid nitrogen for 
RNA or protein analysis. For the number and genotype of animals which were used in this 
study see table 12. 
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4.5.1 Preparation of whole mount tail skin (WM)  
 
Whole mounts of mouse tail epidermis (WM) were prepared as previously described (Braun et 
al., 2003; Niemann et al., 2003). Briefly, whole skin was removed from the tail of mice and 
incubated for 1-4h at 37°C in freshly prepared 5mM EDTA/1xPBS. The epidermis was then 
separated from the dermis and fixed in 3.4% formaldehyde for 2h at RT. Fixed whole mounts 
were stored in 1x PBC at 4°C or stained. 
 
 
4.5.2 Isolation and cultivation of primary keratinocytes 
 
Primary keratinocytes were isolated from the epidermis of wild-type and Ihh EKO littermates 
at postnatal day 1-3 (P1-P3). The skin of these mice was harvested and incubated overnight, 
floating on dermis side down, in 0.25 % Trypsin/EDTA at 4°C. On the next day the epidermis 
was separated from dermis using forceps (Rheinwald and Green, 1975; Rheinwald, 1989; 
Watt, 1994). The epidermis was comminute using scalpels and incubated for 1h at 37°C in 
DMEM/Ham’s F12 in thermocycler. Finally the epidermal cells were seeded onto collagen I 
coated 6-well plates. In order to provide optimal support for the isolated primary 
keratinocytes, they were co-cultured with mitomycin c pretreated fibroblasts. J2/3T3 
fibroblast was cultured in fibroblast medium (4.1.3) at 37°C and 5% CO2. Therefore fibroblasts 
were seeded out onto collagen I coated 6-well plates and treated with mitomycin c for 2-3 h 
at 37 °C. In order to remove mitomycin c, fibroblasts were washed twice with PBS after 
incubation. Isolated primary keratinocytes were co-cultured in DMEM/HAM´s F12 
keratinocyte medium (4.1.3) at 32°C and 5% CO2. 
 
 
4.5.3 Passaging of primary keratinocytes 
 
Medium was changed every 2 days. When keratinocytes reached confluency of 80-90% cells 
were washed with 1x PBS/0.02% EDTA at RT for 5min and incubated with 0.05% (v/w) 
tyrupsin/0.02% (v/w) EDTA (Gibco/Invitrogen) at 37°C until the cells detached (2-5min).  
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After centrifugation for 5min at 700rpm, cells were reseeded onto collagen G coated 6 cm 
dishes, without fibroblasts, to retain only keratinocytes for further cultivation. This collagen G 
coated culture dishes were prepared before using 40µg/ml collagen G diluted in 1xPBS. 
Culture dishes were incubated with 4 ml of collagen G/PBS at 4 °C overnight and washed twice 
with 1x PBS prior use.  
 
 
4.5.4 Determination of cell number by CASY Counter 
Cell numbers were determined by a CASY cell counter. 100μl cell suspension was diluted in 
10ml of an electrolyte buffer (CASYton) and aspirated through a precision measuring capillary 
with a defined size. In the measuring capillary the cells were scanned with a frequency of 
1x106 measurements per second. This procedure uses a low voltage field, produced between 
two platinum electrodes that are traversed by the cells, thus producing electric signals. These 
signals are analysed by amplitude, pulse, width, course of time and resulting pulse area. 
Thereby, it is possible to simultaneously separate cell debris, viable cells, dead cells and cell 
aggregates. 
 
 
4.6. Histological analysis 
 
 
4.6.1 Sectioning 
 
Sections of formalin-fixed (4% Formalin, 2h, RT and in 70% ethanol O/N) and paraffin-
embedded back skin and tumour tissue (5-10µm) were dehydrated. Subsequently, 
haematoxylin-eosin (H&E) staining (4.5.3) was performed according to the standard protocols 
(4.5.2). Skin or tumour section (4-7µm) of OCT-embedded frozen tissue were fixed with 1-4% 
(w/v) PFA/PBS or acetone, respectively depending on the antibody used in the experiment, 
and subjected for further immunofluorescent analyses. 
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4.6.2 Deparaffining of paraffin sections 
 
In order to remove paraffin from tissue sections, paraffin sections of back skin or tumours 
were incubated twice in xylol for 10min and 15min. Slides were incubated in a series of 
ethanol solutions with 100%, 90%, 70% and 50% ethanol for 5 min. Sections were rehydrated 
in ddH2O and tap water different staining methods were performed as described in the 
following chapter. 
 
 
4.6.3 Haematoxylin-Eosin (H&E) staining 
 
Back skin sections were incubated for 2 min in hematoxylin, followed by an incubation step of 
3 min in dH2O. Then sections were incubated for 10 sec in eosin, followed by short incubations 
in: 70 % ethanol, 95 % ethanol, isopropanol and xylol. Skin sections were mounted with Pertex 
 
 
4.6.4 Immunofluorescence (IF) 
 
4.6.4.1 IF staining with Paraffin embedded sections 
 
Sections of back skin or tumours were unmasked for 40-45min in a steamer (2100-Retriver) 
under pressure at 121°C using the antigen retrieval solutions: 
 
Demasking buffer 
10x buffers, target retrieval solution (Dako real) for BrdU staining  
10x R-buffer, (Electron Microscopy Science) for P53 staining 
10x citrate buffer, target retrieval solution (Dako) for all other staining 
 
 
Subsequently, the sections were washed for 5 min with 1x PBS and blocked with 10% serum 
derived from the species from which the secondary antibody was purified or in 0.25% FGS. 
The sections were incubated for 1-2h at RT in a humidified chamber. After washing the  
              Material and Methods 
 
57 
 
samples with 1x PBS the slides were incubated in a humidified chamber O/N with the primary 
antibody (Table 10) diluted in blocking solution. After washing in PBS, the slides were 
incubated with the secondary antibody coupled to Alexa-488 or Alexa-594 (Table 11) diluted 
in blocking solutions. Nuclei were counterstained using propidium iodide (PI) or DAPI (Sigma 
Aldrich). After a final washing, the slides were mounted with Mowiol/DABKO and stored at 
4°C in the dark. 
 
 
4.6.4.2 IF staining of frozen sections 
 
Skin or tumour was removed from the dorsal region of mice and immediately embedded in 
OCT mounting media and placed on dry ice for cryo-sectioning. The cryo-sections (4-7μm) 
were fixed with 1-4% (w/v) PFA/PBS or ice-cold acetone for 5-10 min at RT or in -20°C, 
respectively depending on the antibody used in the experiment. Tissue were blocked in 1xPBS 
containing 1-2% BSA or 0.25 fish skin gelatin (FSG) and in case for 1-2h in a humidified 
chamber. After washing with blocking solution the slides were incubated with the primary 
antibody (Table 10) diluted in blocking solution O/N at 4°C in a humidified chamber. After 
washing in 1x PBS the slides were incubated with the secondary antibody coupled to Alexa-
488 or Alexa-594 (Table 11) for 1-2h diluted in blocking solution. Nuclei were counterstained 
using PI or DAPI (Sigma Aldrich). After a final washing, the slides were mounted with 
Mowiol/DABKO and stored at 4°C in the dark. 
 
 
4.6.4.3 IF staining using anti-Lrig antibody 
 
For immunofluorescent staining the cryo-sections (4-7μm) were fixed with 2% (w/v) PFA/PBS 
15 min at RT, respectively depending on the antibody used in the experiment. Tissue were 
blocked in 1xPBS containing (2% BSA, 0.5%FSG, 0.1%Tx100) for 2-3h in a humidified chamber. 
After washing with blocking solution the slides were incubated with primary antibody (Table 
10) 1:50 diluted in blocking solution (2% BSA, 0.5%FSG, 0.1%Tx100 in 1x PBS) O/N at 4°C in a 
humidified chamber. After washing in 1x PBS the slides were incubated with the secondary 
antibody coupled to Alexa-488 (Table 11) diluted 1:1000 in blocking solution for 1-2h at RT. 
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Nuclei were counterstained using DAPI (Sigma Aldrich). After a final washing with PBS 
followed with ddH2O, the slides were mounted with Mowiol/DABKO and stored at 4°C in the 
dark. 
 
 
4.6.4.4 IF staining using anti-Plet1 and -SCD1 antibody 
 
For immunofluorescent staining cryo-sections (4-7μm) were immediately blocked in 0.25% 
FGA/PBS for 2h in a humidified chamber at RT. After washing with 1x PBS the slides were 
incubated with the first primary antibody anti-Scd1-S15(Table 10) diluted 1:100 in blocking 
solution O/N at 4°C in a humidified chamber. After washing in 1x PBS the slides were 
incubated with the first secondary antibody coupled to Alexa-594 (Table 11) diluted 1:500 in 
blocking solution for 1-2h at RT, followed by three time PBS washing and were fixed with 4% 
(w/v) PFA/PBS for 5min at RT. After washing with 1x PBS tissue were blocked in 1% BSA/PBS in 
15min RT in a humidified chamber. After washing with PBS the slides were incubated with the 
second primary antibody anti-Plet1 (Table 10) 1:5 diluted in blocking solution (1% BSA/PBS) 
for 5h in RT. After washing in 1x PBS the slides were incubated with the second secondary 
antibody coupled to Alexa-488 (Table 11) diluted 1:500 in blocking solution for 1h at RT. 
Nuclei were counterstained using DAPI (Sigma Aldrich). After a final washing with PBS 
followed with ddH2O, the slides were mounted with Mowiol/DABKO and stored at 4°C in the 
dark. 
 
 
4.6.4.5 IF staining of paraffin sections using anti-K6a and -SCD1 antibodies 
 
The paraffin-embedded back skin and tumour tissue (5-10µm) were dehydrated and 
unmasked for 40-45min in steamer (2100-Retriver) at 121°C using the antigen retrieval (Dako 
real). After washing with PBS slides were blocked in 0.25% FGS/PBS for 2h in a humidified 
chamber at RT. After washing with 1x PBS the slides were incubated with the first primary 
anti- SCD1-S15 antibody (Table 13) diluted 1:100 in blocking solution O/N at 4°C in a 
humidified chamber. The next day, after washing in PBS the slides were incubated with the a 
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cocktail of first secondary antibody coupled to Alexa-488 (Table 14) diluted 1:750 and second 
primary antibody anti-K6a (Table 13) dilute 1:400 in blocking solution O/N at 4°C. Next day 
after washing in PBS the slides were incubated with the second secondary antibody coupled 
to Alexa-594 (Table 11) for 1h diluted 1:500 in blocking solutions. Nuclei were counterstained 
using DAPI (Sigma Aldrich). After a final washing with PBS followed with ddH2O, the slides 
were mounted with Mowiol/DABKO and stored at 4°C in the dark. 
 
 
4.6.4.6 IF staining of paraffin sections using anti-BrdU and -K14 antibody 
 
The paraffin-embedded back skin and tumour tissue (5-10µm) were dehydrated and 
unmasked for 40-45min in steamer (2100-Retriver) at 121°C using the antigen retrieval (Dako 
real). After washing with PBS slieds were blocked in 10% NGS/PBS for 2h in a humidified 
chamber at RT. After washing with 1x PBS the slides were incubated with the first primary 
anti-BrdU antibody (Table 13) diluted 1:10 in blocking solution O/N at 4°C in a humidified 
chamber. After washing in 1x PBS the slides were incubated with the a cocktail of first 
secondary antibody coupled to Alexa-488 lgG1 (Table 14) diluted 1:1000 and second primary 
antibody anti-K14 (Table 13) dilutet 1:2000 in blocking solution for 2h at RT, followed by three 
time PBS washing. After washing in 1x PBS the slides were incubated with the second 
secondary antibody coupled to Alexa-594 (Table 11) for 1h diluted 1:500 in blocking solution. 
Nuclei were counterstained using DAPI (Sigma Aldrich). After a final washing with PBS 
followed with ddH2O, the slides were mounted with Mowiol/DABKO and stored at 4°C in the 
dark. 
 
 
4.6.4.7 IF staining of paraffin sections using anti-BrdU and –K6 antibody 
 
The paraffin-embedded back skin and tumour tissue (5-10µm) were dehydrated and 
unmasked for 40-45min in steamer (2100-Retriver) at 121°C using the antigen retrieval (Dako 
real). After washing with PBS slides were blocked in 10% NGS/PBS for 2h in a humidified 
chamber at RT. After washing with 1x PBS the slides were incubated with the first primary 
anti-BrdU antibody (Table 13) diluted 1:10 in blocking solution O/N at 4°C in a humidified 
              Material and Methods 
 
60 
 
chamber. After washing in 1x PBS the slides were incubated with the a cocktail of first 
secondary antibody coupled to Alexa-488 lgG1 (Table 14) diluted 1:1000 and second primary 
antibody anti-K6a (Table 13) dilute 1:600 in blocking solution for 2h at RT, followed by three 
time PBS washing. After washing in 1x PBS the slides were incubated with the second 
secondary antibody coupled to Alexa-594 (Table 11) for 1h diluted 1:500 in blocking solution. 
Nuclei were counterstained using DAPI (Sigma Aldrich). After a final washing with PBS 
followed with ddH2O, the slides were mounted with Mowiol/DABKO and stored at 4°C in the 
dark. 
 
 
4.6.4.8 IF staining of Whole Mount (WM) tissue 
 
Fixed epidermal sheets were blocked for 1h with buffer containing 0.5% milk powder, 
0.25%FGS and 0.5% TritonX-100 in TBS-WM (0,9% NaCl, 20mM HEPS, PH7.2) (Braun et al., 
2003). Following O/N incubation with primary antibodies at RT (gentle agitation), WMs were 
washed with 0.2% Tween-20/PBS for 4h. Secondary antibodies were then applied O/N at RT 
and washing steps were repeated for 4h. Epidermal sheets were rinsed with ddH2O before 
mounting with Mowiol/DABKO and stored at 4°C in the dark. 
 
 
4.6.4.9 IF staining of cells 
 
For immunofluorescent staining cells were seeded overnight on cover slips, washed with 1x 
PBS and fixed with 4% PFA/PBS 5min. To remove the PFA cells were washed again in 1x PBS 
and treated with 0.2-0.5% Triton X-100 detergent in 1x PBS for 2-10min at RT and antibodies 
gain access into the cells. Afterwards, cells were blocked in with 10% serum derived from the 
species from which the secondary antibody was taken or in 0.25% FGS or 1% BSA for 1h at RT 
dependent on staining. Then were incubated with primary antibody (Table 13) diluted in 
blocking solution for 2h at RT or O/N at 4°C. After this first incubation, the cells were washed 
three times with 1x PBS and incubated again for 1h at RT with the appropriate secondary 
antibody (Table 14) followed by three washing steps in 1x PBS alone and one wash step in 
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ddH2O. Nuclei were counterstained using PI or DAPI (Sigma Aldrich). After a final washing, the 
slides were mounted with Mowiol/DABKO and stored at 4°C in the dark. 
 
 
4.6.4.10 IF staining of cells with anti-BrdU antibody 
 
For immunofluorescent staining cells were seeded overnight on cover slips, washed with 1x 
PBS and incubate with keratinocytes medium which contain 1:100 or 1:200 BrdU (16mg/ml in 
H2O) for 1h at at 37°C and 5% CO2. Further cells were washed three time with 1x PBS and fixed 
with 4% PFA/PBS 10min at RT. To remove the PFA, cells were washed again three time with 1x 
PBS and treated with solution containing  2N HCl and 0.5% Triton X-100/PBS detergent for 
10min at 37°C followed by  two time 1x PBS wash step. Afterwards, cells were blocked in with 
blocking solution (4.1.3) for 30-60 min at RT then washed again with 1x PBS. Then cells were 
incubated with primary antibody (Table 13) 1:25 diluted in 1%BSA/PBS auf shaker for 45min at 
RT. After this first incubation, the cells were washed five times and incubated again for 30min 
at RT with the appropriate secondary antibody (Table 14) 1:500 dilution in blocking solution 
followed by five washing steps in with 0.01% Tween-20/PBS and one wash step in ddH2O. 
Nuclei were counterstained using PI or DAPI (Sigma Aldrich). After a final washing, the slides 
were mounted with Mowiol/DABKO and stored at 4°C in the dark. 
 
 
4.6.4.11 TUNEL assay  
 
DeadEnd™ Fluorometric TUNEL System was used for TUNEL-assy. Cells were fixed in 4% 
formaldehyde in PBS for 25 min at 4°C. The slides were washed twice in PBS, 5 min each time 
and premeabilised in 0.2% Triton-X-100/PBS for 5 min. Slides were washed twice in PBS, 5 
minutes each time. Further, cells were equilibrated with 100μl Equilibration Buffer at RT for 
5–10 min. Cells were incubated with 50μl of TdT for 60min at 37°C in a humidified chamber. 
Afterward, slides were immersed in 2X SSC for 15min and washed three time with PBS, 5min 
each time. Nuclei were counterstained using DAPI (Sigma Aldrich). After a final washing, the 
slides were mounted with Mowiol/DABKO and stored at 4°C in the dark. 
(www.promega.com/tbs). 
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   Table13: Primary antibodies used for IF  
Antibody Host Dilution Reference 
K14 rabbit 1:1000  
1:2000 
(costaining 
with BrdU) 
Covance 
K10 rabbit 1:250 Covance 
K15 mouse IgG2a 1:750 Neomarker 
K81 (hHb1) guinea pig 1:750 Progen  
K6a rabbit 1:600 Covance 
Involucrin rabbit 1:750 Covance 
SCD1 (S-15) goat 1:100 Santa Cruz  
BrdU mouse 1:10 tissue 
1:25 cells 
BD 
Ki67 mouse 1:200 TEC-3, DAKO 
Lrig1 goat 1:50 R&D System 
Plet1 rat 1:5 Raymond et al., 
2010 
P53 (CM5) rabitt 1:500 Novocastra 
Leica,Microsystems 
 
 
 
   Table 14: Secondary antibodies used for IF 
Antibody Host Dilution Reference 
Alexa-488 
mouse IgG1 
goat 1:1000 tissue  
1:500 cells 
Invitrogen 
Alexa-488 
mouse 
IgG2a 
goat 1.1000 Invitrogen 
Alexa-488 
rabbit IgG 
donkey 1.1000 Invitrogen 
Alexa-488 
chicken IgG 
goat 1.500 Invitrogen 
Alexa-594 
rabbit IgG 
donkey 1:500 
1:1000 
Invitrogen 
Alexa-488 
goat IgG 
donkey 1:1000 Invitrogen 
Alexa-488 
guinea pig 
goat 1:750 Invitrogen 
Alexa-488 
rat IgG 
donkey 1:500 Invitrogen 
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4.9 Statistical Methods 
 
Statistical analysis of differences in tumor multiplicity were carried out using non-parametric 
methods, as tumor burden data is non-normative (Matsumoto et al., 2003, Abel et al., 2009). 
Data sets were analysed for statistical significance using a two-tailed unpaired Student´s t-
test. All P-values below 0.05 were considered significant. All statistical analyses were done 
using Microsoft Exel and GraphPad Prism 5, SPSS 7. 
 
 
 
4.10 Computer programs and data bases 
 
 
Table 15: Programs and data bases 
Data base/program  Internet adresse application 
Blast 
 
http://blast.ncbi.nlm.nih.gov/Blast.cgi primer alignment 
Ensemble.org 
 
http://www.ensembl.org/index.html gene/exon structure 
primer localization 
Fast PCR 
 
 primer analysis 
GraphPad Prim 5 
 
http://www.graphpad.com/prism/Prism.htm statistical analysis 
Image J 
 
http://rsb.info.nih.gov/ij/ 
http://rsb.info.nih.gov/nih-image 
western blot 
analysis 
Lucia G & G/F V.4.82 
 
 Image processing 
Primer 3 
 
http://fokker.wi.mit.edu/primer3/input.htm primer design 
Step One Plus  
Version2 
 qRT-PCR 
quantification 
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5 Results 
 
In order to address the function of Ihh signalling in skin development and tumour formation Ihh 
loss-of-function studies were performed. Conventional Ihh knockout mice, which have been 
generated previously, die during embryonic development at day E10.5 to E12.5 or directly after 
birth due to circulatory abnormalities and respiratory failure (St-Jacques et al., 1999). 
Consequently, Ihh null mice could not be used for studying the role of Ihh in postnatal skin 
development and tumourigenesis. Therefore we generated epidermal specific Ihh knockout mice 
(Ihh EKO) to study the function of Ihh during the skin morphogenesis and epidermal regeneration 
in normal and patho-physiological conditions. 
 
 
5.1 Generation of epidermal specific Ihh knockout mice (Ihh EKO) 
 
To generate a conditional epidermal knockout for Ihh, homozygous mice carrying a floxed Ihh 
gene (Ihh fl/fl) (Razzaque et al., 2005) were crossed with mice expressing Cre-recombinase under 
control of the human Keratin 14 promoter (K14Cre) (Hafner et al., 2004) (Fig. 10A). In mice 
epidermal Keratin 14 (K14) expression begins from embryonic stage day 9.5 (E9.5) and remains 
constantly active throughout life (Koster and Roop, 2004). The K14 promoter is active in the 
proliferating basal layer of the interfollicular epidermis (IFE), the sebaceous gland (SG) and the 
outer root sheat (ORS) of the hair follicle (HF) (Fig. 10B). Crossing of K14Cre mice with different 
reporter strains [Rosa26 (Mao et al., 1999) and pLuhflox/flox (Ayral et al., 1998)] it was shown that 
from E15 onwards the complete IFE, SG and HF contain active Cre-recombinase (Hafner et al., 
2004).  
In Ihh floxed mice the start codon and exon1 of the Ihh gene are flanked by loxP sites (Fig. 10C). 
The floxed region encodes the part of the Ihh peptide (Hh-N), which is functionally important for 
binding to the Patched receptor and consequently for the transduction of the Hh signal (chapter 
3.2.1). The Cre enzyme is active in basal keratinocytes of the skin and therefore exon1, including 
the start codon are deleted and Ihh cannot be translated. Consequently, all descendent cells, 
including the differentiated keratinocytes, lack functional Ihh. 
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To examine the efficiency of Cre recombinase in keratinocytes, PCR analysis was performed of 
genomic DNA (gDNA) isolated from tail biopsies or split epidermis from the tail of mice at 
postnatal day 2 (P2) (Fig. 10D). Primers designed for amplifying the exon1 region of Ihh (Fig. 10C) 
can identify the Ihh floxed (flox 1,2kb) and Ihh deleted allele (∆400bp). PCR analysis of gDNA 
from homozygous Ihh EKO (K14Cre// Ihh fl/ fl) tails (k1, K2, k4) shows both the Ihh deleted 
(∆400bp) and floxed (flox 1,2kb) band. This is expected since the DNA is derived from tissues 
both with and without Cre expression. The DNA amplified from tails of control (CO) mice lacking 
Cre (Ihh fl/ fl) show only the non-deleted floxed band (flox 1,2kb). 
In contrast, the PCR analysis of gDNA from homozygous Ihh EKO (K14Cre//Ihhfl/fl) epidermis 
shows a single Ihh deleted band (∆400bp) resulting from effective Cre recombination in Ihh EKO 
mice (k1, k2, k4). The additional unexpected band (∼750 bp) seen in the PCR analysis of tail 
biopsies from homozygous Ihh EKO mice might result from the hybridisation of floxed and 
deleted products. The PCR analysis was performed with several littermates and in different 
postnatal stages (P0-P3), always yielding the same results. Also gDNA sequencing of epidermis 
from CO and Ihh EKO mice showed the expected nucleotide deletions in the floxed region of Ihh 
EKO mice, while the CO mice contained the complete Ihh gene (data not shown).  
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Figure 10: Generation of epidermal specific Indian hedgehog knockout mice (Ihh EKO). 
(A) Mice expressing the Cre recombinase enzyme under the control of the Keratin 14 promoter (K14Cre) were 
crossed with mice homozygous for floxed Indian hedgehog allele (Ihh fl/fl). (B) The Keratin 14 (K14) promoter 
induces Cre expression in the basal cells of Interfollicular epidermis (IFE), Hair follicle (HF) and Sebaceous gland (SG). 
(C) Genomic map of the mouse Ihh locus shows loxP site flanking exon1 and start codon (ATG) and position of 
primers for PCR detection of Ihh exon1 deletion. (D) PCR analysis of genomic DNA isolated from tail biopsies showing 
both deleted and wt for Ihh allele from homozygous Ihh EKO mice (k1, k2, k4). PCR analysis of genomic DNA from 
split epidermis from homozygous Ihh EKO tail showing the high efficiency of deletion in the epidermis (k1, k2, k4) 
and no deletion in epidermis of CO (Ihh fl/fl) mice (c3, c5, c6). The size of loxP-flanked allele fragments (flox:  c3, c5, 
c6) is 1,2kb and the size of deleted allele band (∆: k1, k2, k4) is 400bp.  
              Results 
 
67 
 
PCR analyses of primary keratinocytes isolated from Ihh EKO (K14Cre//Ihh fl/fl) and CO (Ihh fl/fl) 
littermates in postnatal day 2 (P2) confirmed the results from mouse biopsies. A single undeleted 
Ihh floxed band (flox 1,2kb) was amplified in primary keratinocytes of CO mice (c3, c5, c6) (Fig. 
11). In contrast, gDNA amplification of Ihh EKO primary keratinocytes showed only the Ihh 
deleted allele (∆400bp) (k1, k2, k4). This means that the K14 promoter and Cre enzyme are fully 
active already at postnatal day 2. 
 
 
 
 
 
Figure 11: High efficiency of Ihh deletion in primary keratinocytes. 
PCR analysis of genomic DNA isolated from primary keratinocytes of new born mice (P2) showing homozygous 
deletion of Ihh homozygous allele with high efficiency (k1, k2, k4). The expected size of floxed allele band (flox:  c3, 
c5, c6) is 1,2kb and the size of deleted allele band (∆: k1, k2, k4) is 400bp.  
 
 
 
Since Ihh EKO epidermis contains only the deleted Ihh allele and epidermis of CO mice contains 
only the complete Ihh allele, for further analysis Ihh fl/fl littermates are used as controls (CO) for 
the evaluation of Ihh EKO mice. 
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5.2 Analysis of epidermal morphology of Ihh EKO mice 
 
Ihh EKO mice showed no general macroscopic abnormalities in size, weight or behaviour. 
Moreover, no differences in appearance of growth and density of dorsal and ventral hair and 
whiskers were observed. In addition in Ihh EKO mice, the time course of hair cycle regeneration 
was normal and showed no delay. To examine whether there is any microscopic morphological 
alteration in the skin of Ihh EKO mice compared to CO a histological analysis was performed. 
 
 
5.2.1 Analysis skin morphology of Ihh EKO mice  
 
Previous studies suggested a potential role of Ihh signalling for sebaceous gland (SG) physiology 
(Niemann et al., 2003; Allen et al., 2003; Takeda et al., 2006; Lo Celso et al., 2008) (chapter 3.4). 
Therefore, the skin of Ihh EKO mice was analysed focusing on SGs. Histological analysis of back 
and tail skin sections revealed normal development of SG, HF and IFE as analysed between 
postnatal day 0 to day 10 (P0-P10) (Fig. 12A). Generally, the first mature sebocytes are 
detectable shortly after birth as SGs develop during HF formation (Niemann, 2009). Formation of 
SG and HF was also investigated by epidermal whole-mount technique (Fig. 12B). No 
morphological alteration in size and shape of SGs and HFs were seen in absence of epidermal Ihh. 
Initial analysis of other skin compartments including dermis, subcutaneous fat and muscles also 
revealed no morphological abnormalities in P0 to P10 stages of development. 
Previous studies performed in non-skin tissues suggested that Ihh regulates cell proliferation and 
differentiation (Vortkamp et al., 1996; St-Jacques et al., 1999; Zhang et al., 2001; van den Brink 
2007; Tsiairis and McMahon, 2009; Bellon e al., 2009; Cortes et al., 2009). Therefore, we 
examined epidermal development in Ihh EKO mice in more detail using differentiation and 
proliferation markers. 
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Figure 12: No morphological abnormalities in back and tail skin during postnatal development (P0-P9) of 
Ihh EKO mice. 
(A) Histological analyses of back skin sections from Ihh EKO and control (CO) mice in early postnatal stages (P0-P9) 
show no morphological change in SG, HF and IFE. (B) Epidermal whole mounts (WM) isolated from tail skin (P0-P9) 
of Ihh EKO (lower panel) also show no morphological abnormalities in HF and SG during morphogenesis compared to 
CO. The analysis of all postnatal stages (P0-P9) was done with n=8-15 mice per genotype with matched littermate 
controls. Scale bars 200µm (A) and (B). H&E: Haematoxylin-eosin staining 
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5.2.2 Sebaceous gland formation is not altered in Ihh EKO mice 
 
To examine whether absence of Ihh affects the differentiation of SGs, expression of stearoyl-
coenzyme A desaturase 1 (SCD1) was analysed. SCD1 has been shown to be an early sebocyte 
differentiation marker (Zheng et al., 1999, Miyazaki et al., 2001). In this experiment, sections of 
back skin (Fig. 13A) and epidermal whole mounts from tails (Fig. 13B) of Ihh EKO and CO mice 
(P0-P9) were stained with antibody against SCD1 (green), K14 (red) and DAPI (blue). In all 
postnatal stages (P0-P9) the expression pattern of SCD1 was not altered in SGs of Ihh EKO mice 
compared to CO. In addition, K14 expression in basal cells of all epidermal compartments was 
not altered. 
Taking together these data indicate that absence of epidermal Ihh does not affect development 
and differentiation of SGs. Whether the differentiation of SG, IFE or HF is altered at later stages 
in Ihh EKO remains to be analysed in more detail. 
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Figure 13: SG morphogenesis and differentiation is not altered in the absence of epidermal Ihh. 
(A) Sebocyte differentiation marker SCD1 (green), co-stained with K14 (red) and DAPI (blue) for nuclear staining. In 
the back skin of Ihh EKO mice (lower panel) the expression pattern of SCD1 during the SG developmental stages (P0-
P9) is not changed compared to control (CO) (upper panel). P5-P9 inset of higher magnification of marked region. 
White arrows point to sebaceous gland. (B) WM epidermis isolated from tail (P0-P9) show also normal SCD1 
expression in Ihh EKO mice (lower panel) compared to CO (upper panel). The Immunofluorescents (IF) analysis of all 
postnatal stages (P0-P9) was done with n=3-5 mice per genotype with matched littermate controls. SCD1 (green) co-
stained with K14 (red). Scale bars 200µm (A), µm (B) and 50µm (Inset A). 
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5.2.3 Ihh stimulates epidermal proliferation in neonatal mice 
 
To test if proliferation of epidermal tissue is altered in Ihh EKO mice different proliferation 
markers were used. We examined the BrdU incorporation after a 1h pulse labelling in the back 
skin of Ihh EKO mice. Skin sections of mice from P0 to P10 were stained with antibodies against 
BrdU (green) and K14 (red) (Fig 14). Interestingly, during the early postnatal stages (P0-P2) in Ihh 
EKO mice the number of BrdU positive cells was reduced whereas in later stages (P3-10) it was 
unchanged. 
Analysis of Ki67 confirmed our results of reduced proliferation in Ihh EKO mice. In both studies 
the effect on proliferation seems to be most pronounced in the IFE. To examine this in more 
detail we quantified the BrdU incorporation in different epidermal compartments separately. 
 
 
 
 
 
 
 
Figure 14: Reduced epidermal cell proliferation in the absence of Ihh during skin development. 
Analysis of BrdU incorporation (green) of the epidermis in Ihh EKO mice (lower panel) compared to CO (upper 
panel). In the early postnatal stages (P0-P2) absence of Ihh in the epidermis significantly reduced the proliferation of 
IFE, but this effect is compensated in later stages (P3-P10). IF analysis with anti K14 (red) and anti BrdU (green) 
antibody of all postnatal stages (P0-p10) was done with n=1-7 mice per genotype with matched littermate controls. 
Scale bar 100µm. 
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BrdU positive cells within the basal layer of the IFE were counted at different developmental 
stages, normalised to the total number of basal cells in the IFE. In the absence of Ihh, cell 
proliferation within the IFE is significantly reduced at P0 (1.8 fold), P1 (1.5 fold) and P2 (1.6 fold) 
whereas at later stages (P3-10) no significant differences were observed (Fig 15B). Taken 
together, these data indicate that epidermal Ihh signalling promotes the proliferation of basal 
cells in the IFE during early stages of skin development. This effect might be compensated by 
other factors during later phases of postnatal development.  
 
 
 
 
 
 
 
 
Figure 15: Reduced cellular proliferation in the IFE of neonatal Ihh EKO mice. 
(A) Higher magnification of back skin of newborn mice (P0) stained for BrdU (green), K14 (red) and DAPI (blue). 
Reduction of proliferation observed in absence of Ihh within the IFE. BrdU incorporation (IP injection, 1h pulse), 
Scale bar 50µm (A). (B) Quantification of BrdU positive cells within the basal layer of IFE (normalised to total number 
of basal cells of IFE) at different postnatal stages (P0-P10). Quantification of BrdU from each postnatal stages (P0-
P10) was done with matched littermates (n=1-7 mice per genotypes) analysing 5-10 different areas per slide using 
ImageJ. Error bars are ± s.d., Student´s t-test, *** P<5x10-14. 
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5.2.4 Ihh regulates epidermal proliferation by keratinocyte-intrinsic signalling 
 
To address whether Ihh stimulates epidermal proliferation by keratinocyte-intrinsic signalling, in 
vitro studies were performed. Primary keratinocytes were isolated from newborn (P2) Ihh EKO 
and CO mice and cultured in low Ca2+ growth medium. In the absence of epidermal Ihh, primary 
keratinocytes show a significant delay until reaching confluency compared to CO. BrdU analysis 
revealed that in absence of Ihh the proliferation of keratinocytes is significantly reduced in vitro 
(Fig. 16A). This experiment was done in triplicate with primary keratinocytes isolated from 3 
independent littermates. Quantification of BrdU positive keratinocytes indicates a 2.4 fold 
reduction in cell divisions in the absence of Ihh (Fig. 16C). 
To test whether the reduction of cell number in absence of Ihh is due to apoptosis, TUNEL assays 
were performed (Fig. 16B). Only very few apoptotic cells were seen and no difference was 
observed between Ihh KO and CO cells. This experiment was also performed in triplicate with the 
same primary keratinocytes as for the BrdU incorporation assay. 
These data demonstrate that Ihh signalling induces proliferation of keratinocytes by 
keratinocyte-intrinsic signalling, without affecting apoptosis. These observations raise the 
question of what reduced epidermal proliferation entails for skin development in Ihh KO mice 
and why Ihh regulation of cell division was only detected in neonatal stages? One possibility is 
that the role of Ihh in the skin during later stages becomes apparent only in stress situations or 
during disease processes.  
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Figure 16: Ihh is required for proliferation in vitro. 
(A) BrdU incorporation assay indicates a dramatic decrease of keratinocyte proliferation in absence of Ihh compared 
to CO. BrdU (green) counterstained with PI (red) for visualisation of nuclei. (B) TUNEL staining (green) indicates that 
the absence of Ihh does not affect apoptosis of primary keratinocytes compared to CO (left panel). In TUNEL assay 
DAPI (blue) was used for visualisation of nuclei. White arrows point TUNEL positive nuclei. (C) The quantification of 
BrdU positive cells indicates 2.4 fold reduction of keratinocytes proliferation in absence of Ihh (red bar; 19.2 ±2.1) 
compared to CO (blue bar; 45.5 ±4.7).For BrdU and TUNEL staining, including BrdU quantification analysis, primary 
keratinocytes were isolated from newborn littermates (P2) (n=3 Ihh EKO and n=2 CO mice), cultured in keratinocyte 
medium and stained in triplicate. 5-7 different areas from each slide were quantified using ImageJ. Scale bar 100µm 
(A) and (B). Error bars are ± s.d., Student´s t-test, ***P<2x10-10. 
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5.3  The function of Ihh signalling for skin tumorigenesis 
 
To investigate the function of Ihh signalling in tumour formation, two epidermal tumour models 
were studied:  
5.3.1 sebaceous tumours  
5.3.2 squamous tumours (benign papilloma and malignant squamous cell carcinoma) 
 
 
5.3.1  The function of Ihh signalling during sebaceous tumour development 
 
To examine the role of Ihh during sebaceous tumour formation in detail, carcinogenesis 
experiments were performed with Ihh EKO (K14Cre+/-//Ihh fl/fl) and CO (Ihh fl/fl) mice, crossed 
to K14∆NLef1 transgenic (tg) mice. The K14∆NLef1 tg mouse is a sebaceous tumour model, 
which was previously generated and characterised by Niemann et al. (2002) (chapter 3.5.1). It 
has been shown that carcinogen (DMBA) treatment of K14∆NLef1 mice is sufficient to induce 
sebaceous tumours at high frequency (Niemann et al. 2007) (Fig. 17). This procedure is called a 
one-stage carcinogenesis experiment since tumour induction does not require the additional 
treatment with a tumour promoter-like phorbol ester derivates. We performed one-stage 
carcinogenesis experiments to analyse the influence of Ihh on tumour formation in a K14∆NLef1 
background. In particular, processes of tumour formation, proliferation and differentiation of 
tumour cells were analysed. 
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Figure 17: Scheme of tumour induction in K14∆NLef1 mice. 
In the one-stage skin carcinogenic experiments, skin of K14∆NLef1 transgenic mice received a single sub-threshold 
dose of DMBA for tumour initiation resulting in sebaceous tumour development. DMBA: 7,12-dimethylbenz(a) 
anthracene. 
 
 
 
5.3.1.1 Ihh does not affect incidence and frequency of sebaceous tumours but 
represses tumour growth 
 
We generated mice with epidermal deletion of Ihh in a K14∆NLef1 background 
(K14∆NLef1/K14Cre//Ihh fl/fl = K14∆NLef1/Ihh EKO). The animals used for the one-stage 
carcinogenesis experiment were 9-week-old in the second telogen. The skin of K14∆NLef1/Ihh 
EKO (n=19) and CO (K14∆NLef1/Ihh fl/fl) (n=17) littermates received a single sub-threshold dose 
of DMBA (100nmol/200µl) or acetone vehicle (K14∆NLef1/Ihh EKO [n=5] and (K14∆NLef1/Ihh 
fl/fl [n=4]) (Fig. 18A). Mice were monitored weekly. The first tumours developed 4 weeks after 
DMBA treatment while none of the mice in control groups (treated with acetone) developed 
tumours. Scoring of tumours was contined for up to 25 weeks after tumour initiation. In both 
K14∆NLef1/Ihh EKO and CO mice tumour incidence was very similar (Fig. 18B).  
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Figure 18: Repression of sebaceous tumour size in the presence of Ihh. 
(A) Time line of one-stage carcinogenesis experiment. Skin of 9 week old Ihh EKO and CO mice, in K14∆NLef1 
background received one application of DMBA or acetone vehicle only. The first tumours were observed 4 weeks 
after DMBA treatment. Scoring of tumours was carried out once a week for up to 25 weeks after tumour initiation. 
(B) Incidence of tumours in K14∆NLef1/Ihh EKO (red line) and K14∆NLef1/Ihh fl/fl (CO) mice. (C) Frequency of 
tumours developing in K14∆NLef1/Ihh EKO (red line) mice. (D) Measurement of tumour size at 25 weeks after DMBA 
treatment indicates significantly larger tumours in K14∆NLef1/Ihh EKO mice (red bar) compared to K14∆NLef1/Ihh 
fl/fl (CO) (blue bar). n=17 K14∆NLef1/Ihh fl/fl (CO), n=19 K14∆NLef1/Ihh EKO mice were treated with DMBA and 
n=4-5 mice per genotype with acetone for analysis of incidence and frequency of sebaceous tumours. n=113 
tumours from n=7 K14∆NLef1/Ihh fl/fl (CO) mice and n=148 tumours from n=10 K14∆NLef1/Ihh EKO mice was used 
for the quantification of tumour size. This experiment was done in duplicate and the result was replicated. Non-
parametric methods, as tumour burden data is non-normative, Student´s t-test, **P=0.002. 
 
 
4 to 10 weeks after tumour initiation 95-100% mice in both, K14∆NLef1/Ihh EKO and CO groups 
developed tumours after DMBA treatment. Between 1 to 12 weeks after tumour initiation the 
frequency of tumours was not significantly different between the two groups. While the 
frequency of tumours in K14∆NLef1/Ihh EKO was slightly reduced from 13 to 25 weeks after 
tumour initiation compared to CO mice. An average number of 13.5 and 16.5 tumours were 
scored for K14∆NLef1/Ihh EKO and CO mice at 25 weeks, respectively. 
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However, two-tailed unpaired student’s t-test revealed no significance of these results (Fig. 18C). 
Interestingly the size of tumours developing in K14∆NLef1/Ihh EKO mice (51 mm2) was 
significantly larger than in CO (33 mm2) (P=0,002) (Fig. 18D). This data indicate the incidence and 
frequency of tumour formation in K14∆NLef1 mice is not affected by Ihh. On the other hand, this 
data suggest Ihh represses tumour size.  
 
 
5.3.1.2 Ihh promotes sebocyte and sebaceous duct fate differentiation in 
 tumours of K14∆NLef1 mice 
 
To further characterise the tumours developing in K14∆NLef1/Ihh EKO mice the histology of the 
tumour tissue was investigated. In CO mice the majority of tumours are sebaceous adenoma, 
which arise from underneath the epidermis and upper region of HF (Niemann et al., 2002). In 
addition, there are some sebaceomas with sebaceous and squamouse, differentiation and very 
few papilloma with small areas of sebocytes. The sebaceous adenoma from CO mice are filled 
with a large number of well differentiated sebocytes (Fig. 19A-C). In contrast, the number of 
sebocytes is dramatically reduced in the sebaceous tumours of K14∆NLef1/Ihh EKO mice (Fig. 
19D-F). Only a few sebocytes were observed at the periphery of the tumours.  
In order to further characterise the tumours and better quantify the contribution of mature 
sebocytes, the tumours were grouped with regard to their size: small tumours (1-4mm 
diameter), medium size tumours (4-8mm) and large tumours (8-16mm). Half of the tumours in 
both K14∆NLef1/Ihh EKO and CO mice were of medium size. However, the number of large 
tumours was increased in K14∆NLef1/Ihh EKO (34%) compared to CO mice (23%) (Fig. 19G) 
The tumours which contained more than 50% sebocytes were counted and their proportion was 
determined relative to the total number of tumours in each group (Fig. 19H). In Ihh EKO mice the 
number of small tumours with differentiated sebocytes was higher, whereas the number of 
medium size and large tumours with well differentiated seboytes was significantly decreased (2.3 
and 3.1 fold) compared to CO mice. These data indicate that Ihh is required for sebocyte 
differentiation, when tumours reach a critical size. 
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Figure 19: Reduced differentiation into sebocytes in tumours of K14∆NLef1/Ihh EKO mice. 
(A-F) Histological analysis of tumours from K14∆NLef1/Ihh EKO mice (H&E staining) (D-F) indicates that number of 
sebocytes is decreased compared to K14∆NLef1/Ihh fl/fl (CO) (A-C). Black arrows indicate regions of sebaceous 
differentiation. The analysis of sebaceous tumours was done with n=100-110 tumours from n=12 mice per 
genotype. Scale bars 100µm (A-F). (G) For further characterisation tumours are grouped according their size 
(diameter), small (1-4mm), medium (4-8mm) and large (8-16mm). This graph shows the percentage of tumours 
relative to the total number of the tumours. (H) Quantification of sebaceous tumours with more than 50% sebocytes 
differentiation in each group. n=44-45 tumours (4-5 tumours per group) from n=4 mice per genotype, Student´s t-
test, ***P<0.0005.  
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To analyse differentiation in sebaceous tumours in detail we checked for expression of the 
sebocyte differentiation marker SCD1 (Fig. 20). As expected in medium and large tumours of 
K14∆NLef1/Ihh EKO mice the SCD1 expression pattern is largely reduced (Fig. 20A-C) whereas the 
CO tumours are filled with SCD1 positive cells (Fig. 20D-F). To consider cellular heterogeneity 
within the tumour western blot analysis (WB) was performed to quantify SCD1 protein levels in 
individual sebaceous tumours (Fig. 20G-J). Lysates from large tumours of K14∆NLef1/Ihh EKO 
(k1-k9) and CO mice (c1-c9) were analysed. In Ihh EKO mice the majority of tumours show a 
significant reduction of SCD1 protein levels confirming the histological observations. Taken 
together, these results imply that Ihh promotes sebocyte differentiation within sebaceous 
tumours.  
Next we wanted to know if Ihh regulates a more general program epidermal differentiation 
within the tumour tissue. Therefore we analysed epithelial differentiation markers characteristic 
for different compartments of the epidermis. 
First we analysed the expression of Keratin 6a (K6a), a marker of sebaceous duct cells (Fig. 21). 
2008 Gu and Coulombe reported that K6a expression by ductal cells of the SG is associated with 
Hh signalling. In addition, K6a marks terminally differentiated cells of the companion layer within 
the HF, which derive from the matrix of the hair bulb during anagen, extend to SG duct (Isthmus 
zone) and are located between the Outer root sheath (ORS) and Inner root sheath (IRS) 
(McGowan and Coulombe, 1998; Coulombe et al., 2004; Hsu et al., 2011). Tumours were stained 
with antibodies against K6a (red) and SCD1 (green) to examine localisation and distribution of 
K6a positive cells with regard to SCD1 positive seobocytes (Fig. 21). In sebaceous tumours of CO 
mice K6a and SCD1 both are highly expressed (Fig. 21A-D & I-K). The K6a positive cell population 
are mostly forms duct-like structures surrounding cysts or cavities. The layer of K6a positive cells 
lining the lumen of the cysts or cavities itself is surrounded by SCD1 positive sebocytes. 
Interestingly, in the absence of Ihh the number of K6a positive cells is dramatically reduced and 
this correlates with the reduction of SCD1 positive cell population (Fig. 21E-H & L-N).  
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Figure 20: Decreased sebocyte differentiation in tumours of K14∆NLef1/Ihh EKO mice. 
(A-F) Analysis of SCD1 (green) expression in sebaceous tumours indicates dramatic reduction of differentiated 
sebocytes in absence of Ihh (K14∆NLef1/Ihh EKO) (D-F) compared to K14∆NLef1/Ihh fl/fl (CO) (A-C). White arrows 
point regions of sebaceous differentiation. The analysis was done with n=23-25 tumours from n=10 mice per 
genotype. SCD1 (green) counterstained with PI (red). Scale bars 100µm. (G) Western blot analysis (WB) was 
performed to quantify the SCD1 protein level in sebaceous tumour of K14∆NLef1/Ihh EKO (k1-k9) and CO (c1-c9) 
mice. SCD1 =38kDa, α-Tubulin=50kDa. (H) Quantification of SCD1 protein level comparied to α-Tubulin on WB using 
ImageJ program indicates a reduction of SCD1 protein in sebaceous tumours lacking Ihh (red bars) compared to CO 
(blue bars) by 1,6 fold higher in Ihh EKO tumours than CO (D). Error bars are ± s.e.m. 
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Figure 21: Ihh promotes differentiation of sebaceous duct fate in sebaceous tumours. 
(A-N) Analysis of K6a (red) and SCD1 (green) in sebaceous tumours indicates dramatic reduction of K6a in the 
K14∆NLef1/Ihh EKO (E-H, L-N) compared to K14∆NLef1/Ihh fl/fl (CO) (A-D, I-K). The dramatic reduction of sebaceous 
duct fate correlates with reduced sebocyte differentiation in tumours. (I-N) Higher magnified view of tumours. The 
analysis was done with n=15 tumours from n=9-10 mice per genotype. Scale bars 100µm. Nuclei are counterstained 
with DAPI. K6a: Keratin 6a. 
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In wound healing experiments K6a expression is seen in proliferating cells and in epithelial 
tumours derived from IFE and HF K6a expression is associated with hyperproliferation (Weiss et 
al., 1984; Mansbridge and Knapp, 1987; Rothnagel et al., 1999; Wojcik et al, 2000). Therefore, we 
analysed whether in the sebaceous tumours K6a expression was associated with the proliferating 
cells. Dividing cells in sebaceous tumours were detected with antibodies against BrdU following a 
pulse of BrdU (Fig 22). Subsequent staining shows that K6a (red) positive cells did not 
incorporate BrdU (green), indicating that the K6a marks differentiated keratinocytes within the 
duct-like areas of tumours, rather than undifferentiated proliferating cells. The BrdU labelling 
experiment also revealed an overall reduction in proliferating cells in tumours lacking Ihh 
compared to tumours of control mice. The proliferation of tumour cells will be described in more 
detail in chapter 5.3.6.  
Our data strongly indicate that Ihh promotes the differentiation of sebocytes and sebaceous 
duct-like cell fates in tumours of K14∆NLef1 mice.  
 
 
 
 
 
Figure 22: Analysis of proliferation in K6a positive tumour cells. 
(A-F) Analysis of K6a (red) and BrdU (green) incorporation to label proliferative cells in sebaceous tumours indicates 
that K6a expressing cells are not proliferative. K14∆NLef1/Ihh EKO mice (D-F) compared to K14∆NLef1/Ihh fl/fl (CO) 
(A-C).The analysis was done with n=15 tumours from n=9-10 mice per genotype. Nuclei are counterstained with 
DAPI. Scale bar 100µm.  
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5.3.1.3 Altered differentiation of tumour cells upon loss of Ihh 
 
Based on our observation that Ihh affects differentiation of sebocytes and sebaceous duct-like 
cell fates in tumours of K14∆NLef1 mice we asked the question whether the differentiation of 
other epidermal cell lineages is also altered. For this purpose we used several epidermal 
differentiation markers.  
Keratin 10 (K10) is expressed in keratinocytes of the spinous and granular layer of the IFE and 
therefore, can serve as a marker for differentiated keratinocytes of the IFE (Fuchs and Green, 
1980). In sebaceous tumours of CO mice K10 was broadly expressed in cell layers surrounding 
the cavities (Fig. 23D). Upon loss of Ihh the number of K10 positive cells is significantly reduced 
and only very few cells facing the lumen of cavities express K10 (Fig. 23G). This experiment shows 
that Ihh influences the differentiation of K10 positive keratinocytes normally seen in tumours of 
K14∆NLef1 mice.  Next, we examined the terminal differentiation marker Involucrin, which is 
expressed in the granular layer as it differentiates into the cornified envelope and in the 
infudibulum. In the sebaceous tumours of CO mice Involucrin expression is strongest in regions 
surrounding the lumen of cavities structures (Fig. 23E). Its expression is dramatically reduced in 
K14∆NLef1/Ihh EKO tumours: Residual expression is again found at the surface of the large 
cavities (Fig. 23H).  
In addition to markers for the IFE we also examined markers for the HF. We tested several 
markers (K28, K32, K75, K82 and K81) known to be expressed in different layers within the HF. 
Only Keratin 81 (K81) was observed to be expressed in the sebaceous tumours. In the HF K81 is 
expressed in the hair cortex and hair cuticle from above the hair bulb to isthmus zone (IZ). K81 
expression is also maintained in tumours derived from this region (Langbein and Schweizer, 
2005).  In CO sebaceous tumours K81 is expressed in several cell layers around the cavities 
regions (Fig. 23F); however K81 is dramatically decreased in the tumours of K14∆NLef1/Ihh EKO 
mice (Fig. 23I).  
 
Taken together these analyses indicate that within the sebaceous tumours Ihh affects the 
differentiation program of keratinocytes, which are specific for different epidermal 
compartments.  
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Figure 23: Altered differentiation of tumour cells in K14∆NLef1/Ihh EKO mice. 
(A) In normal back skin K10 (green) is expressed in the spinouse and granular layer of IFE, marking the suprabasal 
layer, (B) Involucrin (green) expressed in the spinous layer of IFE and is an early marker of the cornified envelope 
and (A) K81 (green) is expressed in the HF in the bulb to isthmus zone and marks cortex and cuticle of the HF. (D-F) 
Sebaceous tumours of K14∆NLef1/Ihh fl/fl (CO) and (G-H) K14∆NLef1/Ihh EKO mice. (D, G) K10 (green) co-stained 
with PI (red). (E, H) Involucrin (green) co-stained with DAPI (blue). (F, I) K81 (green) co-stained with PI (red). K10 
analysed tumours: n=9-13 tumours from n=6-8 mice per genotype. Involucrin analysed tumours: n=3 tumours from 
n=3 mice per genotype. K81 analysed tumours: with n=9-13 tumours from n=6-8 mice per genotype. Scale bars 
100µm, panel (D, G, F, I) and (E, H) same magnification. K10: Keratin 10; Inv: Involucrin; Keratin 81: K81. 
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5.3.1.4 Ihh controls the number of progenitor cells in sebaceous tumours 
 
Given the observation that keratinocytes differentiation markers were reduced in K14∆NLef1/Ihh 
EKO compared to CO we wondered whether this was accompanied by a change in the number of 
progenitor cells. We first analysed the Keratin 15 (K15) cell population. K15 is a marker for the 
stem cell population within the HF bulge (Liu et al., 2003; Morris et al., 2004). K15 derived 
progenitors contribute to HF regeneration during the hair cycle and to IFE regeneration after 
injury (Ito et al., 2007). In addition, recent studies done in our laboratory demonstrate that K15 
derived progeny continuously reconstitutes the SG during skin homeostasis.  The K15 derived 
cells also contribute to the development of sebaceous tumours (Petersson 2010). Therefore, we 
investigated if the K15 positive cell population (HFSCs) is present within sebaceous tumours and 
how it is affected by Ihh. Interestingly, the sebaceous tumours of both K14∆NLef1/Ihh EKO and 
CO mice did not contain K15 positive cells (data not shown).  
During normal skin homeostasis Lrig1 (Leucine-rich repeats and immunoglobulin-like domains 
protein 1) positive cells are localised in the junctional zone (JZ) of HF and contribute to SG and 
IFE renewal (Jensen et al., 2009). Plet1 (Placental expressed transcript 1) positive cells are 
located in the Isthmus region (IZ) which extends to the sebaceous gland. Based on their 
proliferative potential Plet1 positive cells have been suggested to mark a committed progenitor 
population of hair follicle keratinocytes (Nijhof et al., 2006).  
To assess the distribution of committed progenitor cells during the sebaceous tumour 
development we analysed the expression of Lrig1 and Plet1 in sebaceous tumours. Lrig1 (green) 
labelling of CO sebaceous tumours (Fig. 24) shows an Lrig1 positive cell layer at the periphery of 
the sebaceous lobes within the tumours (Fig. 24A-C). In the tumours of K14∆NLef1/Ihh EKO mice, 
Lrig1 expression appears to be reduced and its distribution is altered compared to CO tumours. 
Lrig1 positive cells are more concentrated in a narrow region facing the cysts in K14∆NLef1/Ihh 
EKO tumours. 
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Figure 24: Expression of Lrig1 is altered in tumours of K14∆NLef1/Ihh EKO. 
In back skin Lrig1 (green) is expressed in the Junctional zone (JZ) of the HF and extends to the SG, contributing in to 
SG and IFE renewal. (D-F) In sebaceous tumours of K14∆NLef1/Ihh EKO mice Lrig1 (green) is ectopically expressed in 
the duct like region and its expression is reduced compared to K14∆NLef1/Ihh fl/fl (CO) mice (A-C). The analysis was 
done with n=8-9 tumours from n=7 mice per genotype. Scale bar 100µm.  
 
 
 
Plet1 staining using the 33A10 antibody (green) was combined with staining for the sebocyte 
marker SCD1 (red) (Fig. 25). In CO sebaceous tumours only a few Plet1 positive cells were 
observed that localised to the periphery of the cysts. The majority of the cells constituting the 
tumour expressed the sebocyte marker SCD1. The loss of Ihh in K14∆NLef1/Ihh EKO tumours led 
to a dramatic change of this expression pattern. The number of Plet1 positive cells surrounding 
the cyst cavities strongly increased while the number of SCD1 positive cells decreased. The SCD1 
positive cells were, in general, restricted to a few islands, separated from the Plet1 positive cell 
population. Plet1 positive cells are found predominantly, but not exclusively, around the cysts.  
These data show that Ihh is involved in determining the relative number of committed 
progenitor cells in sebaceous tumours. One possible explanation for this result is that Ihh 
promotes transition from the committed progenitor fate to the terminally differentiated state in 
tumour cells.   
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Figure 25: Increased Plet1 positive tumour cells in K14∆NLef1/Ihh EKO mice. 
(A) In back skin Plet1 (green) is expressed in the isthmus zone (IZ) of HF and in the sebaceous gland duct. In tumours 
of K14∆NLef1/Ihh EKO mice Plet1 (green) expression is significantly increased (E-G) compared to tumours of 
K14∆NLef1/Ihh fl/fl (CO) mice (B-D). Plet1 (green) counterstained with DAPI (blue). The analysis was done on n=7-9 
tumours from n=6 mice per genotype. Scale bars 100µm.  
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5.3.1.5 Ihh induces proliferation in sebaceous tumours 
 
So far these studies of Ihh function demonstrate that within sebaceous tumours Ihh is required 
for the differentiation of keratinocytes at the expense of committed progenitor cell populations.  
We next asked the question whether Ihh affects the proliferation of epithelial cells in sebaceous 
tumours. To this end we administered a pulse of Bromodeoxyuridine (BrdU) to label proliferating 
cells shortly before harvesting the tumour tissue. Sections of the sebaceous tumours were co-
stained with BrdU (green) and K14 (red) (Fig. 26). Interestingly, after loss of Ihh the number of 
BrdU positive cells is dramatically reduced within sebaceous tumours (Fig. 26E-H) when 
compared with CO tumours (Fig. 26A-D). The majority of proliferating cells are located in the 
tumour lobules whereas very few cell divisions are observed within the stroma of tumours if 
either K14∆NLef1/Ihh EKO or CO mice. In the K14∆NLef1/Ihh EKO tumours the small number of 
BrdU positive cells was restricted to the cyst-like structures. 
Quantification of BrdU positive cells (normalised to total cell number) in sebaceous tumours 
indicates in average a 2.2 fold reduction in absence of Ihh (11.3 ± 2) compared to CO (25.1 ± 2.9) 
(Fig. 26K). In addition, analysis of Ki67 immunostaining supports our observation that in 
sebaceous tumours of Ihh EKO mice keratinocyte proliferation is reduced (data not shown). This 
result was surprising because the determination of tumour size indicates that the tumours of 
K14∆NLef1/Ihh EKO mice are significantly larger than tumours of CO mice (Fig. 18D). However, 
morphological analysis of sebaceous tumours revealed that in absence of Ihh the histology of 
tumours was different when compared to tumours of CO mice. The tumours lacking Ihh contain a 
high number of large cavities often with only thin layers of epithelial cells surrounding the lumen 
(e.g. compare Fig. 26C to Fig. 26G). This observation suggests that the large size of the tumours 
from K14∆NLef1/Ihh EKO mice is caused by changes in the architecture of the tumour tissue, 
rather than by an increase in tumour cell number.                                                               
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Figure 26: Reduced proliferation in sebaceous tumours of K14∆NLef1/Ihh EKO mice. 
 (A-J) Analysis of BrdU (green) incorporation in sebaceous tumours. BrdU (green) co-stained with K14 (red) and DAPI 
(blue). (E-H, J) In sebaceous tumours of K14∆NLef1/Ihh EKO mice BrdU positive cells are dramatically reduced 
compared to CO mice (A-D, I). (I-J) Higher magnification of sebaceous tumours. (K) Quantification of BrdU positive 
cells indicates a 2.2 fold reductions in sebaceous tumours lacking Ihh (red bar; 11.3 ± 2) compared to CO (blue bar; 
25.1 ± 2.9). BrdU positive cells were normalised to total number of sebaceous tumour cells. The analysis was 
performed with n=11-20 tumours from n=7-11 mice per genotype. Scale bar 100µm (A-H) and 50µm (I-J). Quantified 
5 different areas on a single slide using ImageJ. Error bars are ± s.d., Student´s t-test, ***P=3x 10-41.  
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5.3.2 The function of Ihh signaling for development of papilloma and  
 progression into squamous cell carcinoma (SCC) 
 
Given our observation that Ihh influences the architecture, proliferation and differentiation of 
sebaceous tumours we wondered whether the same applies to other types of skin tumours like 
papilloma and squamous cell carcinoma (SCC). To this end, we performed a two-stage 
carcinogenesis experiment (Fig. 27). In this experiment, a single treatment of the skin with a 
tumour initiator e.g. DMBA (7,12-dimethylbenz[a]anthracene) induces many mutations 
including, occasional mutations in H-Ras. Subsequently, the skin is repeatedly treated with a 
tumour promotion agent, the phorbol ester TPA (12-O-tetradecanoylphorbol-13- acetate) which 
stimulates proliferation, thereby expanding the cell pool containing DMBA-induced mutations.  
Finally, this leads to the development of benign papilloma. Eventually, a small number of 
papilloma will progress into malignant SCC (Fig. 27). Susceptibility to two-stage skin 
carcinogenesis in mice is known to be highly dependent on the genetic background of the mice 
(DiGiovanni, 1992). The Ihh EKO mice used for this study are in more tumour-resistent C57BL/6 
background. Therefore, TPA was applied three times weekly with a dose of 6nmol/200µl per 
mouse. The application of DMBA was 100nmol/200µl per mouse (Sundberg et al., 1997; Abel et 
al., 2009).  
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Figure 27: Scheme of a two-stage skin carcinogenesis experiment. 
In the classical two-stage skin carcinogenesis experiment mice receive a single topical, sub-threshold dose of 
carcinogen (DMBA) for tumour initiation and repeated treatment of tumour promoter (TPA). Mice develop benign 
papilloma which can progress in malignant SCC. (Modified after Weinberg, 2007). 
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5.3.2.1 Ihh reduces the incidence and frequency of papilloma and promotes 
 tumour growth 
 
In order to address the function of Ihh in papilloma formation 9 weeks old mice (onset of second 
telogen) were used for a two-stage carcinogenesis experiment. The skin of Ihh EKO (n=19) and 
CO (Ihh fl/fl, n=19) littermates was treated with a single sub-threshold dose of the carcinogen 
DMBA to initiate mutations or with acetone vehicle (Fig. 28A). One week later mice received the 
tumour promoter TPA or acetone vehicle three times weekly up to 25 weeks to promote cell 
growth (Fig. 28A). In addition control groups, for both genotypes, Ihh EKO and CO, were treated 
with DMBA alone (n=5mice per genotype), TPA alone (n=5mice per genotype) and acetone alone 
(n=1 mouse per genotype). None of the mice in the control groups developed tumours indicating 
that all observed effects were due to the experimental treatment. 
First tumours were observed 13 weeks after DMBA treatment for both genotypes. Scoring of 
tumours was carried out once a week for up to 50 weeks following DMBA treatment. 
Interestingly, in Ihh EKO mice both incidence (Ihh EKO=90% and CO=68 % mice with tumours) 
and tumour frequency (Ihh EKO=2.9 and CO=2.1 tumour/mouse) were increased then compared 
to CO mice. The most pronounced effect (P<0.05) was observed between 19 to 23 weeks after 
tumour initiation (Fig. 28B, C). In addition, 17-50 weeks after DMBA treatment mice lacking Ihh 
carried significantly smaller papilloma than CO mice (Fig. 28D) and this effect was more 
pronounced at later time points of the tumour experiment (P<0.04). 
Our data indicate that Ihh suppresses the development of benign papilloma in mice, but once 
tumours are established Ihh promotes proliferation of tumour cells to increase size of the 
tumours.  
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Figure 28: Ihh suppresses incidence and frequency of papilloma but increases tumour size. 
(A) Time line of two-stage skin carcinogenisis experiment. (B) Ihh EKO mice (red line) showed an increased incidence 
of papilloma compared to CO (Ihh fl/fl) (blue line). (C) The frequency of papilloma is also higher in Ihh EKO (red line) 
mice (P<0.05 between 19-23 weeks after DMBA). (D) Quantification of tumour size indicates that mice lacking Ihh 
(red line) develop significantly larger tumours than CO mice (blue line) (P<0.05 between 34-46 weeks after DMBA). 
n=19 CO, n=20 Ihh EKO with DMBA/TPA, n=10 mice per genotype for acetone controls, Student´s t-test. 
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5.3.2.2 Increase in progression of benign papilloma into malignant 
 carcinoma in Ihh EKO mice 
 
One important observation from the two-stage carcinogenesis experiment was that a higher 
number of papilloma (2.5 fold) progressed to invasive SCC (19.6%) in Ihh EKO compared to CO 
mice (7.9%) (Fig. 29A). Furthermore, while conversion of papilloma into SCC was seen for the first 
time at 26 weeks after tumour initiation in both Ihh EKO and CO mice, a significantly higher 
number of tumours had progressed into SCC in Ihh EKO at the end of the experiment (55% Ihh 
EKO mice vs. 16% of CO mice) (Fig. 29B). 
 
 
 
 
 
Figure 29: Increased tumour progression into SCC in Ihh EKO mice. 
(A) Number of papilloma progressing to SCC in Ihh EKO mice is 2.5 fold higher than in Ihh fl/fl (CO) mice (B) incidence 
of formation of SCC in Ihh EKO (red) and CO (blue) mice. CO: n=3 SCC from n=3 mice; Ihh EKO: n=11 SCC from n=11 
mice was recorded. For more detail see (Fig. 28). Student´s t-test, ***P<0.0005 
 
 
Papilloma of CO mice show a clear layering of the thickened epidermis in which the transition to 
the cornified layer is always visible (Fig. 30A-C).  Papilloma from Ihh EKO mice on the other hand 
frequently showed less differentiation of the suprabasal layers (data not shown). In particular, a 
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clearly discernable cornified layer was frequently lacking (Fig. 30E). This observation is 
corroborated by staining for K10, a marker for suprabasal keratinocytes (Fig. 30I-N). The number 
of K10 positive cells is strongly reduced in papilloma of Ihh KO mice (Fig. 30L-N) compared to 
papilloma of CO mice (Fig. 30I-K). Together these data suggest that Ihh influences the cellular 
composition of papilloma by promoting keratinocyte differentiation.   
The phenotypic difference between absence and presence of Ihh is even more pronounced in the 
case of SCC. While SCC from CO mice show distinct epithelial lobules that allow one to distinguish 
stromal from epithelial areas (Fig. 30D), SCC from Ihh EKO mice have a more homogeneous 
organisation with small epithelial islands interspersed with stromal tissue (Fig. 30F).  Moreover, 5 
out of 11 SCC from Ihh EKO mice were largely composed of poorly differentiated tissue lacking 
separate stromal and epithelial compartments (Fig. 30G-H). In these poorly differentiated SCC 
high numbers of mitotic figures were observed (see insets in Fig. 30G-H). These tumours show 
histological similarity to spindle cell carcinoma, an aggressive, albeit relatively rarely occurring 
subtypes of SCC (Abel et al., 2009; Klein-Szanto, 1989). 
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Figure 30: Reduced K10 expression in squamous tumours and increased progression into SCC in Ihh EKO mice. 
Histological analysis of papilloma (PAP) from Ihh EKO mice (E), Ihh fl/fl (CO) (A-C) and SCC from Ihh EKO mice (F-H) 
compared to SCC in Ihh fl/fl (CO) mice (D). Mitotic figures were frequently observed in poorly differentiated SCC of 
Ihh EKO mice (G-H) Inset of high magnified view. Black arrows point to mitotic cells. The analysis of tumours was 
done with n=38 tumours from n=19 CO mice and n=56 tumours from n=20 mice. (I-N) In Ihh EKO mice (L-N) the 
papilloma are poorly differentiated and the number of K10 (green) positive cells is reduced compared to Ihh fl/fl 
(CO) (I-K). The analysis of tumours was done with n=3 tumours from n=3 mice per genotypes. Scale bar 100µm (A-N) 
and 20µm of (Inset D, G, H)  
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5.3.2.3  Metastasis of SCC in Ihh EKO mice 
 
During the course of the tumour experiments every sacrified mouse was dissected and all organs 
were checked for gross-morphological abnormalities. At the end of the two-stage tumour 
experiment 2 out of 20 Ihh EKO mice (of age 60 and 68 weeks, respectively) were found to have 
metastases in lymph nodes (Fig 31B-C). Affected lymph nodes were found in different areas of 
the body. No CO mouse was observed with metastasis to any organ (Fig 31A). Histological 
analysis of metastases in lymph nodes (Fig 31B-C) demonstrates morphology similar to that of 
SCC (Fig 31A). Immunostaining for K14 (green), a marker of basal epithelial cells, shows K14 
expression in the majority of keratinocytes in the SCC (Fig 31E) as well as in the cells which have 
invaded the lymph nodes of the two Ihh EKO mice (Fig 31F-G). In contrast, no K14 positive cells 
could be detected in lymph nodes of CO mice (Fig 31H). Although more mice need to be analysed 
in the future these results indicate that Ihh inhibits the occurrence of metastasis. 
Taking together the two-stage carcinogenesis experiments suggests that Ihh inhibits the initiation 
of benign papilloma, the progression of papilloma to SCC and the acquisition of metastatic 
behaviour. However, the data also suggest that Ihh promotes proliferation of tumour cells. 
 
 
 
Figure 31: Ihh suppresses the metastasis of SCC. 
 (A) Histology of SCC, (B-C) lymph nodes with metastases  and (D) lymph node with non invasive SCC in Ihh EKO mice. 
H&E: Haematoxylin-eosin staining. (E-H) Metastasis of lymph nodes was labelled with anti K14 (green) antibody 
counter stained with PI (red). Scale bars 100µm (A-D) and (E-H). 
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5.3.2.4  Ihh stimulates proliferation in papilloma  
 
Measurements of tumour size suggesed that proliferation was altered in benign papilloma of Ihh 
EKO mice. Therefore, we analysed BrdU incorporation. We restricted our analysis to papilloma of 
medium size (4-8mm) to avoid heterogeneity due to differences in tissue organisation. To assure 
that the BrdU positive nuclei were confined to epithelial cells within the heterogeneous tumour 
tissue, tumour sections were also immunostained with an antibody detecting K14 (Fig. 32A-J). 
The vast majority of keratinocytes within the papilloma are positive for K14 in both Ihh EKO and 
CO mice. In papilloma of control mice the majority of dividing cells are located at the periphery 
of epithelial lobes within the tumour (Fig. 32A-D, I). Only very few cells in S-phase are observed 
within the stroma of papilloma from both Ihh EKO and CO mice (data not shown). In contrast, the 
number of proliferating cells was dramatically reduced in absence of Ihh (Fig. 32E-H, J). The 
quantification of BrdU positive cells revealed a twofold reduction in mice lacking Ihh (15.8 ± 1.1) 
compared to CO mice (31 ± 0.9) (Fig. 32K).  
These data indicate that the reduced size of papilloma measured in Ihh EKO mice (Fig. 27D) is a 
consequence of inhibited proliferation of undifferentiated tumour cells.   
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Figure 32: Reduced proliferation in squamous tumours of Ihh EKO mice. 
(A-J) BrdU incorporation was analysed. BrdU (green) co-stained with K14 (red) and DAPI (blue). (E-H, J) In papilloma 
of Ihh EKO mice the BrdU positive cells are dramatically reduced compared to CO mice (A-D, I). (I-J) Higher 
magnification of papilloma co-stained with BrdU (green), K14 (red) and DAPI (blue). (K) Quantification of BrdU 
positive cells in medium size papilloma lacking Ihh (red bar; 15.8 ± 1.1) compared to CO (blue bar; 31 ± 0.9). The 
BrdU positive cells normalized to the total number of the DAPI positive nuclei. The analysis was done with n=5-6 
tumours from n=4-5 mice per genotype. Scale bars 100µm (A-H) and (I-J). Error bars are ± s.d., Student´s t-test, 
***P=3x10-39. 
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5.4 Molecular mechanisms of Ihh signalling in skin tumours and normal skin 
 
5.4.1 Ihh regulates p53 nuclear accumulation in benign squamous 
 papilloma 
 
Recent studies have revealed links between the p53 tumour suppressor and Gli1 in maintaining 
neural stem cell number and brain tumour formation (Clement et al., 2007; Stecca and Ruiz i 
Altaba, 2009; Prykhozhij, 2010; Malek et al., 2011). To address the question whether Hh 
signalling could also play a role in regulating p53 in skin tumours, we analysed benign squamous 
tumours of KO and control mice for p53 expression. p53 immunfluorescence staining (green) was 
performed on sections of medium size papilloma (4-8mm diameter) of Ihh EKO and CO mice (Fig. 
33A-L). Interestingly, in papilloma lacking Ihh the number of p53 positive nuclei is significantly 
higher than in tumours of CO mice. This observation correlates with our previous results 
demonstrating reduced proliferation upon loss of Ihh. Since p53 is an important mediator 
controlling cellular proliferation, one possible explanation for our results could be that Ihh 
signalling promotes proliferation by reducing p53 nuclear accumulation.  
 
Next we investigated if regulation of p53 is also seen in other types of skin tumours lacking Ihh.  
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Figure 33: p53 positive cell numbers are altered in papilloma of Ihh EKO mice. 
(A-L) Analysis of p53 (green) expression counterstained with PI (red). In papilloma of Ihh EKO mice (E-H, K-L) nuclear 
accumulation of p53 is dramatically increased compared to CO (A-D, I-J). (I-L) Higher magnified view of paillomas. 
n=4 tumours from n=4 CO mice and n=6 tumours from n=6 Ihh EKO mice were used for this analysis. Scale bars 
100µm. 
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5.4.2 Ihh regulates p53 in sebaceouse tumours 
 
Previously, it has been demonstrated using specific immunfluorescence staining that sebaceous 
tumours developing in K14 ∆NLef1 tg mice were either negative for p53 or had only a small 
number of p53 positive cells (Niemann et al. 2007). In addition, it was shown that Ihh expression 
is dramatically increased in sebaceous tumours (Niemann et al., 2003). Therefore, we 
inverstigated if p53 levels are changed in sebaceous tumours lacking epidermal Ihh. To this end, 
we performed western blots analysis to determine the p53 protein level in sebaceous tumours. 
Analysis of 9 tumours from n=9 K14∆NLef1 /Ihh EKO (k1-k9) and n=9 CO (c1-c9) mice indicates 
that within the majority of sebaceous tumours lacking Ihh, p53 protein level is increased 
compared to tumours of CO mice (Fig. 34A). Some variation in p53 level was seen, most likely 
reflecting the cellular heterogeneity of tumours. On average the p53 protein level is fourfold 
increased in sebaceous tumours of Ihh EKO mice compared to CO (Fig. 34D).  This data clearly 
indicates that in addition to squamous papilloma Ihh regulates p53 in sebaceous tumours of 
K14∆NLef1 transgenic mice. 
 
 
 
Figure 34: Ihh affects the level of p53 protein in sebaceous tumours. 
(A)  Western blot analysis (WB) was performed to quantify p53 protein levels in sebaceous tumours of 
K14∆NLef1/Ihh EKO (k1-k9) and CO (c1-c9) mice. GAP-DH was used for a loading control. P53=53kDa, GAP-
DAH=38kDa. (B) Quantification of p53 protein level using ImageJ standardised to GAP-DH. K14∆NLef1/Ihh EKO (red 
bars) compared to K14∆NLef1/Ihh fl/fl (CO) (blue bars). Error bars are ± s.e.m, Student´s t-test, *P<0.05. 
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5.4.3 Ihh regulates p53 during epidermal morphogenesis 
 
The regulation of p53 levels seen in tumours of Ihh EKO mice raised the question whether Ihh 
affects p53 during normal skin development. Western blot analysis with lysates of skin samples 
indicates no consistent difference in total p53 protein amount during postnatal stages (P0-P10) 
between Ihh EKO and CO mice (data not shown). However, lysates were prepared from skin 
tissues containing dermal and epidermal cells and thus do not allow one to detect aberrant p53 
levels specifically in keratinocytes. Therefore we analysed p53 expression by immunofluorescent 
antibody staining in the skin of neonatal mice between P0 to P10 (Fig. 35A). In skin of CO mice 
few p53 positive nuclei were observed.  In contrast, in absence of epidermal Ihh the number of 
p53 positive nuclei is significantly increased until P10 during postnatal development. 
Quantification of these immunostainings revealed that the number of p53 positive cells was 9 to 
37 fold higher in the epidermis of Ihh EKO mice when compared to CO littermates (Fig. 35A). 
Accumulation of p53 was observed in keratinocytes of the IFE, HF and SG. Interestingly, the 
strongest increase of the p53 signal was detected in the infundibulum of the HF. Additionally, 
p53 accumulation was also seen at later stages of skin development (P14) and in adult Ihh EKO 
mice  (6 month and 12 month of age) (data not shown). No nuclear p53 was detected in 
undamaged adult skin of control mice. 
Together with our analysis of skin proliferation (chapter 5.2.3) the data show a strong correlation 
between reduced proliferation during early postnatal stages (P0-P2) and p53 accumulation in the 
absence of epidermal Ihh. However, an increased number of p53 positive nuclei were also 
observed in the epidermis during later development and in the adult skin of Ihh EKO mice 
although no changes in epidermal proliferation was detected. In the future it will be important to 
understand the molecular mechanism of p53 regulation by Ihh. However, our data indicate that 
modulation of p53 by Ihh is not tumour specific but also occurs during normal skin homeostasis.   
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Figure 35: Stimulation of nuclear accumulation of p53 in the epidermis of Ihh EKO mice. 
(A) Detection of p53 (green) in the skin of Ihh EKO (lower panel) and CO (upper panel) mice at postnatal stages (P0-
P10). (B) Quantification of p53 positive nuclei during postnatal stages (P0-P10) in Ihh EKO (red bars) and CO (blue 
bars) mice. p53 quantification and staining of each postnatal stage (P0-P10) was done with matched littermate 
samples (n=2-5 mice per genotypes) in duplicate and analysing 5-10 different areas (position) per slide using ImageJ. 
Scale bar 50µm. Error bars are ± s.d., Student´s t-test, ***P<0.0005. 
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6 Discussion 
 
Over the past years several groups have shown that Hh signalling plays an important role for 
sebaceous gland (SG) physiology both in humans and mice (Niemann et al., 2003; Allen et al., 
2003, Takeda et al., 2006; Lo Celso et al., 2008; Gu and Coulombe, 2008; Bonfanti et al., 2010; 
Séquaris et al., unpublished data). Among the three Hh ligands only Ihh is expressed in SG 
during normal skin homeostasis, as well as in differentiated sebocytes of sebaceous tumours 
(Niemann et al., 2003; Svard et al., 2006). However the role of Ihh for skin development, and 
in particular for the differentiation of SG, has not been investigated by functional approaches 
so far. Therefore, normal skin development and skin tumour formation were investigated in 
mice lacking epidermal Ihh (Ihh EKO). This analysis has three major outcomes which will be 
discussed: 
 
• Although Ihh is not essential for SG development during normal skin homeostasis, it is 
required for normal cell proliferation in neonatal skin.  
• Ihh plays a major role in patho-physiological conditions of the skin. It affects the 
morphology of both sebaceous and benign squamous tumours. In particular, it plays a 
crucial role for the differentiation and proliferation of tumour cells. 
• During normal skin homeostasis and during tumourigenesis Ihh suppresses nuclear 
accumulation of p53. This effect was especially striking and unexpected for normal skin 
development since no morphological alterations were detected during skin 
homeostasis 
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6.1 The role of Ihh during epidermal differentiation  
 
Our analysis of epidermal differentiation of mouse skin shows that the loss of epidermal Ihh 
does not lead to gross morphological changes nor to abnormal SG differentiation. However, 
the sebaceous tumours of Ihh EKO mice demonstrate a dramatic reduction of both sebocytes 
and sebaceous duct fate differentiation. Based on these results and previous studies, which 
indicate that the Hh pathway is involved in sebocyte and sebaceous duct differentiation in 
vivo and in vitro (Niemann et al., 2003, Allen et al., 2003; Gu and Coulombe, 2008; Séquaris et 
al., unpublished data), we suggest that Ihh regulates the specification of sebocyte and 
sebaceous duct fate and is involved in epidermal lineage selection in tumours.  
Ihh has been shown to regulate differentiation during development and homeostasis of many 
organs such as the lateral plate mesoderm, bone, prostate, pancreas and gut (Zhang et al., 
2001; Wijgerde et al., 2002; Razzaque et al., 2005; Tsiairis and McMahon, 2009; Vortkamp et 
al.; 1996; St-Jacques et al., 1999; Dakubo et al., 2008; van den Brink etal., 2004; van den Brink 
2007; van Dop et al., 2010). In most organs in which a role of Ihh has been described, Shh 
signaling also has an important function. For instance, during gut development Ihh and Shh 
are both expressed in the colonic crypt but in different cell populations. This is very similar to 
the situation in the skin where Ihh and Shh both are expressed in distinct epidermal 
compartments and most likely play different roles during skin development (Fig. 36). In the 
colon, Ihh is expressed by mature colonocytes at the luminal end of the crypt and in the 
junctional zone. Here, Ihh regulates colonocyte differentiation, while Shh is expressed around 
the precursor cells at the base of the colonic crypt to control mesenchymal patterning and to 
inhibit smooth muscle differentiation (Ramalho-Santos et al., 2000; Sukegawa et al., 2000; 
Berman et al., 2003; Mao et al., 2010; Waghray et al., 2010; Saqui-Salces and Merchant, 
2010). In the skin Shh is expressed in the matrix of the hair bulb and induces proliferation of 
keratinocytes constituting different hair lineages (St-Jacques et al., 1998; Chiang et al., 1999; 
Sato et al., 1999; Wang et al., 2000; Callahan and Oro, 2001; Oro and Higgins 2003) while Ihh 
is expressed in differentiated sebocytes (Niemann et al., 2003). By extension from our 
observation that Ihh is important for sebocyte differentiation within the sebaceous tumour, 
we suggest that Ihh plays a similar role during normal skin homeostasis (Fig. 36).  
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Figure 36: Hh ligand expression in the colonic crypt and the pilosebaceous unit. 
Schematic view of expression pattern of Ihh (red) and Shh (blue) in the colonic crypt (left) (modified from van 
den Brink et al., 2004) and in the pilosebaceous unit (right). In the colonic crypt Shh is expressed in the precursor 
cells at the base of the colonic crypt. Ihh is expressed by differentiated colonic enterocytes at the luminal end of 
the crypt and induces coloncytes differentiation. In the pilosebaceous unit, matrix cells of the hair bulb express 
Shh. Ihh is expressed in the mature sebocytes in SG. 
 
 
During normal skin development the loss of Ihh did not lead to obvious histological 
abnormalities. One possible explanation for these observations is a functional compensatory 
mechanism by Shh.  Shh and Ihh are closely related to each other and share 90% amino acid 
identity in the region of the signalling N-terminal peptide (Echelar et al., 1993; Ingham and 
McMahon, 2001). The interaction of both ligands with the same receptor, Ptch1, indicate that 
Shh and Ihh have a similar capacity and range of signalling during mammalian development of 
different organs (Ingham and McMahon, 2001; McMahon et al, 2003; Varjosalo and Taipale, 
2008). Indeed, the loss-of-function analysis of Hh pathway components in organs, which 
express both Shh and Ihh, revealed that Shh and Ihh have partially redundant functions during 
tissue development and regeneration. For instance a redundant function of Shh and Ihh has 
been reported in muscle, pancreas, prostate and gut (Ramalho-Santos et al., 2000; Zhang et 
al., 2001, Aubin et al., 2002; Jason Doles, et al., 2006; Mao et al., 2010; van den Brink, 2007). 
In addition, Hh signals can act as a long-range signal over ∼200µm (more than 100 cells) as 
shown in the vertebrate limb bud (Zhu and Scott, 2004; Huangfu and Anderson, 2006). During 
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hair morphogenesis Shh is up-regulated in the hair placode and later in the bulb of the HF 
from 14.5 day postcoital (dpc) to postnatal day 14 (P14). Therefore, potential long-range 
signalling of Shh and consequently a compensation of the Ihh function by Shh are possible.  
Alternatively, Hh ligands may diffuse from the dermal compartment within the skin and 
activate the Hh pathway within the epidermal compartment. Examples for epidermal Hh 
ligand diffusion from other compartments have been described. For instance, a recent study 
shows that Shh derived from sensory nerves adjacent to the HF can induce Hh pathway 
activation in the stem cells of the HF bulge (Brownell et al., 2011). Signalling between 
epithelial and stromal compartments was also reported in tumours derived from other organs 
such as the pancreas (Nolan-Stevaux, 2009; Shaw and Bushman, 2007). The fact that around 
50% of the small tumours (1-4mm diameter) in Ihh EKO mice show sebocyte differentiation, 
while with increased tumour size the sebocyte differentiation is dramatically reduced, might 
be explained by an increased distance between sebocyte precursors and the stromal 
compartment potentially producing Hh ligands in large tumours. In addition, the few 
sebocytes observed in medium (4-8mm) and large (8-16mm) tumours were mostly located at 
the tumour margin adjacent to stromal tissue.  
Another possibility is that the Hh pathway is activated non-canonically. Indeed, it has been 
shown that Gli1 is regulated through a Smo-independent mechanism in neoplastic pancreatic 
ducts. Here, Gli transcription depends on TGF-β and K-Ras and is required independently from 
Shh-Ptch-Smo to maintain the transformed phenotype (Nolan-Stevaux, 2009).  Such a 
mechanism need to be considered and might contribute to a compensation for the loss of Ihh 
in the skin.  
To further investigate potential compensatory mechanisms, future studies should be 
performed in which Shh levels are monitored upon Ihh EKO.  An accurate analysis of possible 
redundancy would be possible by inducing a double kockout of Shh and Ihh in the epidermis. 
Furthermore, the expression of all Hh ligands in the dermis should be analysed to evaluate the 
possibility of Hh signalling from the dermis.  
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6.2 A role of Ihh in controlling epidermal cell divisions 
 
Our data reveal a general function of Ihh in regulating epidermal cell division during skin 
development and tumour formation. During mammalian development the Hh signalling 
pathway has been shown to regulate cellular proliferation in different tissues. For instance, 
Shh signalling has a proliferative effect in somites (Fan et al., 1995), retina (Jensen and 
Wallace, 1997, Wang et al., 2005), lung (Bellusci et al., 1997, Pepicelli et al., 1998), skeletal 
muscle (Duprez et al., 1998), granual cell precursors in the cerebellum (Wechsler-Reya and 
Scott, 1999; Ruiz i Altaba et al., 2002), and also the skin (Oro et al., 1997; St-Jacques et al., 
1998). In neuronal cells, Hh controls proliferation through a number of different mechanisms. 
For instance, it can shorten the cell cycle or induce resting precursor cells to re-enter the cell 
cycle. Among the molecular mechanisms involved are the transcriptional up-regulation of the 
G1-phase cyclins D and E (Kenney and Rowitch, 2000), the direct regulation of the G2- phase 
cyclin B (Barnes et al., 2001), the maintenance of the phosphorylation of retinoblastoma 
protein (RB) (Kenney and Rowitch, 2000) and the inhibition of the cell cycle inhibitor p21 (Fan 
and Khavari, 1999) and p53 (Stecca and Ruiz i Altaba, 2009). Hh signalling might also be 
directly involved in controlling self-renewal of stem cells. In the hematopoietic system, Shh 
was shown to induce proliferation of early precursors by regulation of BMP signalling 
(Bhardwaj et al., 2001). The multiple ways by which Hh signalling can interfere with cell cycle 
regulation could explain why mutations in Hh pathway components have been found in many 
types of cancer. Since Hh exerts multiple functions in cell differentiation, abnormal Hh 
signalling might have different implications for each type of cancer.  
Recently, a classification of tumours with aberrant Hh signalling has been proposed (Barakat 
et al., 2010).  The tumours are grouped according to the stage when Hh becomes important 
for the neoplastic process. The first category comprises tumours for which tumour initiation 
and maintenance of tumour growth depends on mutations in Hh pathway components such 
as Ptch1 or Smo. Examples of this type include medulloblastoma, Rhabdomyosarcoma and 
BCC (Xi et al., 1997; Pazzaglia et al., 2002; Gailani et al., 1996, Hahn et al. 1996, Xi et al., 1998; 
Johnson et al., 1996; Dahmane et al., 1997; Goodrich et al., 1997; Oro et al., 1997; Barakat et 
al., 2010). The second category includes cancers in which Hh signalling does not lead to 
tumour initiation but is important for tumour growth and maintenance. Examples of this  
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category include colon and pancreas cancers (Barakat et al., 2010). There is also an 
unclassified group of cancers, in which the Hh pathway is implicated but its exact role is not 
clear yet, e.g. prostate cancer and lymphomas. It has been suggested that activation of Hh 
target genes in lymphomas and some other tumours might increase production of anti-
apoptotic factors such as Bcl-2 and Bcl-xL (Barakat et al., 2010).  
In agreement with the broadly observed function of Hh signalling in controlling proliferation, 
our analysis shows that lack of Ihh significantly reduces proliferation of keratinocytes during 
early skin development, and of primary keratinocytes in vitro without effecting apoptosis. In 
addition, proliferation is reduced upon loss of Ihh in papilloma and sebaceous tumours. With 
regard to sebaceous tumours the absence of Ihh does not change incidence and frequency of 
tumours. Thus, in sebaceous tumours Ihh contributes to maintenance and growth of the 
tumours and therefore they could be classified in the second category.  
Since Ihh controls proliferation and regulates differentiation of epithelial cell lineages during 
sebaceous tumour formation, three possiblities are conceivable by which Ihh could contribute 
to tumour development: 
(a) Ihh may control the transition from a multipotent SC/progenitor population to lineage 
specific progenitor cells. This would explain our observation that absence of Ihh not only 
affects sebocyte markers (SCD1, K6a positive cells), but also causes a reduction in the number 
of cells expressing markers for the spinous and granular cells (K10, Involucrin positive cells) as 
well as for cells of the HF linaege (K81 positive cells).  
(b) Ihh might act on lineage-specific progenitors. The fact that Plet 1, which has been 
suggested to be a marker for a more committed progenitor cell fate (Nijhof et al., 2006; 
Raymond et al., 2010), was dramatically expanded supports this model. However, in this 
scenario it is more difficult to explain why loss of Ihh affects several epidermal lineages at the 
same time. Either Ihh is required for lineage progression of several committed progenitors or 
the loss of one differentiated cell type, e.g. the sebocytes leads indirectly to differentiation 
defects in other lineages.  
(c) Ihh is not required for lineage progression but plays a role in the maintenance of the 
differentiated state. In this scenario sebocytes would maintain their state of differentiation  
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within sebaceous tumours by autocrine signalling and support the differentiation of other 
lineages by paracrine signalling. However, the fact that ectopic Hh signalling can induce 
ectopic SGs and sebaceous ducts shows that Ihh has the potential to act in an instructive way. 
Therefore, it is unlikely that Ihh fulfils only maintenance function in sebaceous tumours. 
In combination, our data support the second model suggesting an action of Ihh on lineage-
specific progenitor cells. The expression analysis of additional differentiation and progenitor 
markers in sebaceous tumours should make it possible to better understand how the cellular 
composition of these tumours changes upon loss of Ihh. This in turn will help to unravel the 
cellular mechanisms controlled by Ihh in tumours.  
While incidence and frequency of sebaceous tumours are not altered upon loss of Ihh, 
papilloma lacking Ihh show increased incidence and multiplicity in spite of reduced tumour 
growth. The reduced tumour growth can be explained by the observation that the 
proliferation of keratinoyctes within these papilloma was twofold lower than in control 
papilloma. A preliminary marker analysis suggests that keratinocytes in papilloma lacking Ihh 
are less differentiated. This was also observed for sebaceous tumours. Interestingly, the 
reduced growth rate and the absence of differentiation in papilloma lacking Ihh is associated 
with a higher rate of tumour progression into SCC and metastasis. Thus, studying the role of 
Ihh in papilloma may provide important insights into the mechanisms underlying the 
transition from benign to malignant tumour growth.  
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6.3 Ihh controls p53 nuclear accumulation  
 
In order to address the mechanism of Ihh signalling for epidermal cell division in the skin and 
in skin tumours we have analysed p53 expression. Interestingly, in the absence of Ihh there is 
a significant increase in nuclear accumulation of p53 in the epidermis and in papilloma. In 
addition, we detected increased p53 protein levels in sebaceous tumours lacking Ihh. In the 
skin of Ihh EKO mice p53 positive cells appear to be primarily localised in the basal layer of the 
IFE and the junctional zone. Together, these data suggest a novel function of Ihh in negatively 
regulating p53 during skin development and tumour formation. 
In the absence of epidermal Ihh, nuclear accumulation of p53 correlates with reduced 
proliferation of keratinocytes in papilloma. During normal skin development epidermal loss of 
Ihh also causes nuclear accumulation of p53 and a reduced number of dividing keratinocytes 
during early stages (P0-P2).  However, the change in nuclear accumulation of p53 also 
occurred in older Ihh EKO mice, which had normal keratinocyte proliferation. We have 
observed an increase in the number of p53 positive cells in up to 12 months old mice. 
Interestingly, these animals had normal skin morphology. Thus, the increased p53 nuclear 
accumulation upon loss of Ihh is a primary consequence and not always associated with 
reduced cell division rate or changes in tissue morphology. Therefore, our data suggest that 
Ihh directly regulates the p53 pathway.  
The situation might be similar to that described for the relationship between Hh and p53 in 
neural progenitor cells where it has been shown that the number of progenitor cells is 
controlled by a negative feedback loop between p53 and Gli1 (Stecca and Ruiz i Altaba, 2009). 
p53 inhibits the activity of Gli1 by interfering with its normal nuclear localisation and by 
directing it to proteasomal degradation. On the other hand, in the mouse brain and several 
neuronal cell lines Gli1 activates Mdm2 expression, an ubiquitin ligase, which ubiquitinilates 
p53 resulting in its degradation (Abe et al., 2008; Stecca and Ruiz i Altaba, 2009; Prykhozhij, 
2010; Malek et al., 2011).  
Previously it has been shown that p53 nuclear accumulation is significantly reduced in 
sebaceous tumours developing in K14∆NLef1 transgenic mice (Niemann et al., 2007).  
It has been suggested that reduction of p53 accumulation is a consequence of blocking Arf in  
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∆NLef1 mice.  Reduced p53 levels lead to down-regulation of the cell cycle inhibitor p21 which 
is likely to play an important role in tumour promotion. The differentiation of sebocytes 
within sebaceous tumours is accompanied by increased Ihh expression. Our results show that 
in the absence of epidermal Ihh differentiation and proliferation of keratinocytes are reduced 
and p53 protein level is increased in sebaceous tumours of K14∆NLef1 transgenic mice. This 
indicates that Ihh and ∆NLef1 exert the same effect on p53 protein levels in sebaceous 
tumours. Therefore, it is possible that the effect of ∆NLef1 on p53 is mediated by Ihh (Fig. 
37a). In this case, increased levels of Ihh induced by ∆NLef1 would lead to a repression of p53.  
Alternatively ∆NLef1 and Ihh could act in parallel and independently negatively regulate p53 
(Fig. 37b).  
 
 
 
 
 
 
Figure 37: Regulation of p53 by Ihh signalling in sebabeous tumours. 
Chemically induced H-ras mutation led to spontaneous formation of sebaceous tumours in a ∆NLef1 background. 
Blocking Wnt signalling by ∆NLef1 promotes tumour differentiation towards the sebocyte fate. ∆NLef1 also 
blocks p53 accumulation and thereby promotes tumour growth. (a) Ihh might act in parallel to ∆NLef1 promoting 
differentiation of sebocytes and blocking p53 accumulation. (b) The effect of ∆NLef1 may be mediated via Ihh.  
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6.4  Open questions and outlook 
 
The data presented here reveal novel functions of Ihh in keratinocytes of normal skin and skin 
tumours, including the control of proliferation in neonatal skin, the promotion of 
differentiation and proliferation in skin tumours and the control of p53 protein levels both in 
normal skin and skin tumours. One key question resulting from our observations is why the 
effects of Ihh are significantly more pronounced during tumour growth than during normal 
skin homeostasis? In particular, how is it possible that Ihh appears to be required for 
keratinocyte differentiation in skin tumours considering no developmental defect was seen in 
normal skin lacking Ihh? Possible compensatory mechanisms the role of Shh for SG 
differentiation should be investigated using an inducible epidermal knockout of Shh.  This 
would allow a late postnatal deletion of Shh minimizing general defects in hair formation. The 
phenotypic effects of a later loss of Shh should be compared to the simultaneous loss of both 
Ihh and Shh in the epidermis. This comparison would reveal the degree of redundancy 
between ligands. It would also provide hints for the existence of redundant signals from the 
dermis. Moreover, potential cellular abnormalities in the skin of single or double KOs could be 
compared to the cellular composition of skin tumours lacking Ihh. This comparison would 
provide insights into the cellular decision processes, which occur in presence or absence of Ihh 
in sebaceous tumours and papilloma. In particular, a better understanding of Ihh dependent 
differentiation in papilloma is required since the lack of Ihh promotes their transition to 
malignant SCC.  
Another key question posed by this work addresses the relationship between Ihh and p53. 
The fact that  loss of Ihh induces the nuclear accumulation of p53 even in postnatal and adult 
mice, which show no obvious skin abnormalities indicates that Ihh might be directly involved 
in the control of p53 levels. Thus, a focus of future work will be to unravel the molecular 
mechanism of Ihh signalling in controlling p53. The expression of several regulators of p53, for 
example Arf and Mdm2, should be analysed in normal skin and skin tumours in presence and 
absence of Ihh. In parallel genetic experiments would be informative. Mutant mice lacking 
both Ihh and p53 in the epidermis should be generated. An analysis of proliferation in the skin 
of these mice would reveal whether the control of cell proliferation by Ihh depends on p53.  
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